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Abstract 
Proper morphogenesis is essential for both form and function of mammalian 
craniofacial and neural tube development. Craniofacial deformities and neural tube 
defects are highly prevalent human birth defects. Although studies concerning 
craniofacial and neural tube development have revealed important genetic and/or 
environmental factors, understanding the mechanisms underlying proper development 
and the defects remain incomplete.  
Among many genes that were cloned as the gastrula organizer genes in 1990s, 
Noggin (Nog), a secreted BMP antagonist, is expressed in the relevant domains during 
craniofacial and neural tube development. Previous studies show that Nog null embryos 
exhibit fully penetrant spina bifida (open spine) and to the lesser extent exencephaly 
(open brain). Moreover, Nog null mice display deformities in skeletal structures 
including defects in craniofacial skeleton. As such, Nog is essential for proper neural 
tube and craniofacial development. However, it is still not clear that which domain(s) of 
Nog are responsible for proper craniofacial development or neural tube closure. In 
addition, it is also an important question when, and in what capacity Nog is necessary 
during development of craniofacial and neural tube.  
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Here, we used mouse genetic approach to assess tissue-specific roles of Nog in 
NCCs and axial midline for craniofacial skeletogenesis, and in the roof palate and axial 
midline for neural tube closure.  
Our mouse genetic approach showed that ablating Nog from the axial midline on 
Chordin (another BMP antagonist) null background caused rostral truncation, namely 
micrognathia which is similar to the phenotype seen in compound knock-out mutant of 
Chordin and Nog (Chrd-/-;Nog+/-). However, neither defects in neural tube closure nor 
thickened mandibular structure that were found in the compound mutant or Nog null 
were present in this class of mutant embryos. Importantly, neural tube defects were not 
found when Nog was ablated in the roof plate either. Instead, enlarged Meckel’s 
cartilage resulted from increased cell proliferation was present when Nog is absent in 
NCCs. Additionally, absence of Nog in NCCs also caused secondary cleft palate due to 
the insufficient palatal shelf elevation caused by enlarged pterygoid bone invasion into 
the developing posterior palatal shelves. Thus, we found a novel mechanism of 
secondary cleft palate. These studies demonstrate that two distinct domains of Nog are 
required in different stages of craniofacial development, although these two domains of 
Nog are not responsible for neural tube closure.  
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1. Introduction  
This chapter includes modified “Development of the Craniofacial Skeleton” 
originally published in Primer on the Metabolic Bone Diseases and Disorders of Mineral 
Metabolism. John Wiley & Sons, Inc., 2013 Aug; pp. 893-903. 
 
1.1 Developmental Biology and Human Congenital 
Malformations 
Developmental biology is the study of the processes through which organisms 
change shapes and establish a complete living system. Studying developmental biology 
help us understand the normal development as well as mechanisms underlying the 
congenital deformities.  
Congenital malformations are structural and/or functional defects of organs or 
body parts present at birth. Among the congenital deformities found in human 
newborns, craniofacial defects such as cleft palate, cleft lip, and micrognathia - 
mandibular hypoplasia occur highest only after the congenital heart deformities. The 
severities of the deformities vary case by case. The congenital craniofacial anomalies 
frequently occur as part of genetic syndromes such as DiGeorge and Treacher Collins 
syndromes. They also appear sporadically as isolated forms. In some cases, 
environmental factors such as teratogenic chemicals and maternal smoking/alcohol 
intake are responsible for the causes.  
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Another common human birth defect is the neural tube defects (NTDs). They are 
mainly divided into two major groups - open NTDs and closed NTDs (Fig. 1.1). Among 
the open NTDs, one that occurs at the spine is called spina bifida and one that occurs in 
the brain is called exencephaly in which the brain is exposed without any protections 
such as skull bone or skin. When the exencephaly progresses the exposed brain 
degenerates and anencephaly (no brain) results. Those individuals may be born but do 
not survive after birth. Some but not all of the NTDs can be prevented by supplementing 
folic acid because pathways and mechanisms causing NTDs are not always same.  
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Figure ‎1.1: Types of NTDs 
NTDs are divided into two categories; open NTDs and closed NTDs. The 
category of open NTDs includes NTDs such as spina bifida and exencephaly. Spina 
bifida occulta, which is most common form of NTDs, and lipomeningocele are included 
in closed NTDs.  
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1.2 Craniofacial Development and Malformations 
Craniofacial skeletal elements are the most developmentally complex skeletal 
structures in mammals. We humans have distinct, identifying facial features, the result 
of small variations in craniofacial development. Such differences are usually benign and 
result in features that make us distinct individuals. However, variable effects of gene 
expression or environmental factors can lead to cosmetic and functional abnormalities.  
Among the congenital deformities found in newborns, craniofacial defects such 
as orofacial clefts, micrognathia and craniosynostosis occur at a frequency second only 
to the congenital heart defects. The severity of craniofacial deformities varies case by 
case. The deformities frequently occur as part of genetic syndromes. They also appear 
sporadically as isolated forms. In some cases, teratogenic chemicals are responsible. 
Such craniofacial deformities may be fatal, but more often impact on quality of life 
because they affect normal breathing and feeding. Unfortunately, there are often 
negative social responses to the deformities, which take a psychological toll on the 
effected person. The etiology of most congenital craniofacial anomalies has just begun to 
be understood. It is essential to clarify the normal and pathological development of 
craniofacial skeletal elements and the underlying molecular and cellular mechanisms. 
This knowledge will enhance our ability to design strategies for future treatment and 
prevention of craniofacial birth defects. 
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1.2.1 Origin of craniofacial skeletal elements and neural crest cells 
Mammalian craniofacial skeletal elements consist of more than twenty small 
bones and cartilages that are formed precisely during development to create functional 
structures - the face and the head. Most facial skeletal elements, collectively the 
viscerocranium, are derived from cranial neural crest cells (NCCs). These pluripotent 
cells are collectively sometimes called “the fourth germ layer” because of the diversity of 
tissues they form. In early craniofacial development, presumptive cranial NCCs arise in 
dorsal midline ectoderm of the midbrain and the hindbrain rhombomeres, undergo an 
epithelial-to-mesenchymal transition, delaminate, then migrate ventrolaterally between 
the ectoderm and endoderm (Fig 1.2A, 1.3). While the rostral cranial NCCs develop the 
frontonasal skeleton and the skull vault, NCCs from each rhombomere faithfully take 
distinct pathways to populate different pharyngeal arches (PA), numbered 
rostrocaudally from 1 to 6. NCCs from rhombomeres 1 and 2 migrate into PA1 and the 
frontonasal process. PA1 gives rise to the incus and malleus of the ears, the mandible, 
and the maxilla.  The frontonasal process gives rise to tissues in the upper half of the 
face, including the forehead, nose, eyes, and philtrum (the vertical groove between the 
nose and the upper lip). NCCs from rhombomeres 3 and 4 migrate into PA2, which 
gives rise to the stapes bone of the middle ear, the styloid process of temporal bone, and 
a part of the hyoid bone (Fig. 1.2A).  
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The rest of the mammalian craniofacial skeletal elements that enclose and 
support the brain and cranial sense organs are called the neurocranium. They compose 
the skull vault and base. While the ventral craniofacial bones and anterior skull base are 
derived from cranial NCCs, most of the bones at the back of the head, including the 
parietal bones and occipital bone, and the posterior part of the skull base are derived 
from both NCCs and paraxial mesoderm (Jeong et al., 2004; McBratney-Owen et al., 
2008) (Fig. 1.2B). The skull vault is formed through intramembranous ossification and 
the cranial base is formed through endochondral ossification (Sahar et al., 2005). 
  7 
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Figure ‎1.2: Origin of craniofacial skeletal elements 
(A) NCCs go through epithelial-mesenchymal transition and migrate 
ventrolaterally from rhombomeres (R) to populate in pharyngeal arches (PA). NCCs in 
R3 and R5 merge with streams of NCCs from neighboring rhombomeres. Bones and 
cartilages derived from each PA are listed. (B) Facial and frontal bones are derived from 
NCCs. Posterior skull base and vault are mostly derived from somitic mesoderm. 
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Figure ‎1.3: NCC formation and migration 
(A) Neural induction begins in the flat neural plate (pink and green). (B) Both 
edges of the neural plate elevate dorsally. (C) Neural folds (purple) are apposed. (D) 
Around closing neural folds, NCCs (yellow) delaminate and migrate ventrally. 
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1.2.2 Palatal development 
Palatogenesis is a dynamic process, with each step crucial for proper 
development of the palate. The palate is divided into two main parts, the primary and 
secondary palate. Both are mostly derived from NCCs of PA1. The primary palate 
develops from the intermaxillary segment, where the medial nasal processes fuse with 
the maxillary process, to form the most anterior part of the definitive hard palate (Figs. 
1.4A and B). Development of the secondary palate begins with downward protrusion of 
the two palatal shelves of the maxillary prominences on either side of the tongue, at the 
fifth week in humans and between embryonic day (E) 11.5 and E12.5 in mice (Figs. 1.4B 
and 1.5A). Interaction between epithelial and mesenchymal cells influences the survival 
and continued proliferation of NCCs necessary for morphogenesis of palatal shelves 
(Rice et al., 2004). 
The downward protrusions of the palatal shelves turn medially and elevate 
horizontally to meet and fuse at the midline, at about the eighth week in humans and 
E14.5 in mice. The tongue meanwhile moves downward to give enough space for the 
palatal shelves to elevate. The primary and secondary palates also fuse together to form 
the complete palate, compartmentalizing the oral and nasal cavities. Fusion of palatal 
shelves involves loss of medial edge epithelium (MEE; Fig. 1.5A), and the cellular 
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processes of apoptosis, epithelial migration, and epithelial-to-mesenchymal transition 
(Jin and Ding, 2006).  
The ventral two thirds of the secondary palate becomes the hard palate, 
containing bone, and the rest becomes the muscular soft palate. Postnatal development 
of the palate may be influenced by osteogenic responses to retain functional integrity 
against mechanical stress, for example, elevated masticatory load increased the bone 
density of secondary hard palate in growing rabbits (Menegaz et al., 2009).   
In addition to environmental risk factors, several genes and signaling pathways 
important for palatogenesis have been identified (Fig. 1.5B). One key pathway involved 
in palatogenesis is BMP signaling. In early embryogenesis, BMPs influence cell 
migration, differentiation, proliferation, apoptosis, and condensation. Later, among 
other roles, BMP signaling promotes osteogenesis and chondrogenesis in skeletal 
formation throughout the body. For example, BMP signaling is important for 
mesenchymal condensation in progenitors of palatal bone (Baek et al., 2011). Altering 
BMP signaling in NCCs or in the oral epithelium results in CP (He et al., 2010; Li et al., 
2011).  
  12 
 
 
Table ‎1.1: Genes important for palatal development. 
Stage Mesenchyme Epithelium 
E12-E13 
Palatal shelf    growth 
Fgf10, Fgf7, Msx1 Fgfr2b, Shh 
E13-E14 
Palatal shelf elevation 
Fgf10, Fgfr1b, Fgf2b, Msx1, TGFβ1, 
TGFβ2 
Fgfr1, Fgfr2b, Shh, Wnt11 
E14-E15 
Palatal fusion 
Bmp2, Bmp3, Bmp4, Fgf10, Msx1 Bmp3, Fgfr2, Shh, TGFβ3 
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BMP2 and BMP7 expression in palatal mesenchyme is regulated by the Msx1 
homeobox gene (Fig. 1.5B), which plays an important role in epithelial-mesenchymal 
interaction throughout embryogenesis. Msx1 null mice display multiple deformities in 
craniofacial skeletal elements, including secondary CP and abnormal tooth and 
mandible development (Satokata and Maas, 1994). Msx1 is also required for expression 
of Shh in the MEE, the site of palatal shelf fusion (Zhang et al., 2002). Expression of Shh 
and BMP2, as well as CP, in Msx1 mutant mice is rescued by transgenic expression of 
Bmp4, suggesting a gene network of BMP and Shh signaling pathways in development 
of palatal shelves (Zhang et al., 2002).  
The Hedgehog signaling pathway also interacts with Fgf signaling in 
palatogenesis. Fgf10 is expressed in mesenchyme, while its receptor, Fgfr2b is expressed 
in epithelium. Fgf10 is required for Shh expression in epithelium. Loss of either can 
cause CP due to insufficient survival or proliferation of NCCs (Rice et al., 2004).  
Current models suggest that apoptosis is the major cellular mechanism for 
palatal fusion (Kaartinen et al., 1995; Proetzel et al., 1995; Taya et al., 1999b). Tgfβ3 
promotes apoptosis in juxtaposed MEE to form a single layered medial edge seam (MES; 
Fig. 1.5B and Table 1.1). Tgfβ3 expression in MEE is regulated by Wnt/β-catenin 
signaling (He et al., 2011).  
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Figure ‎1.4: Development of the face and the palate in humans. 
(A) Frontonasal, maxillary, and mandibular prominences form in 4th week. By 
6th week, nasal prominences develop from frontonasal prominence.  (B) Ventral view of 
palate development. Around 5th week palatal shelves from maxillary prominences grow 
downward on the either side of the tongue. Growing palatal shelves start elevating 
medially in the 7th week. By 10th week, secondary and primary palates fuse together to 
form complete palate. 
  15 
 
Figure ‎1.5: Coronal view of palatogenesis and gene networks during 
palatogenesis. 
 (A) Palatal shelf (PS), nasal septum (N), tongue (T), medial edge epithelium 
(MEE), medial edge seam (MES). (B) Complex gene networks in the palatal shelves. 
Molecular signaling events during epithelial-mesenchymal interactions of palatogenesis 
are depicted. 
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1.2.3 Orofacial cleft 
Orofacial clefts, among the most common congenital malformations, result from 
failure in the joining of bilateral facial structures during development. They are divided 
in three large groups, cleft lip with cleft palate (CL/P), cleft lip (CL) only and CP only. 
Approximately half of the CL patients also manifest CP, considered a secondary 
consequence of the primary imperfection of premaxillary fusion. Thus, CP only may be 
etiologically distinct from CL/P. CP emanates from defective unification of the palatal 
shelves. Mechanisms leading to this failure include defects in palatal shelf growth, 
palatal elevation, and palatal shelf adhesion. 
CP is subdivided into hard palate cleft, soft palate cleft, complete palate cleft, and 
bilateral palate cleft (Fig. 1.6). Patients often suffer from complications causing speech 
and feeding difficulties, frequent ear infections, dental problems as well as problems in 
psychological development (Stanier and Moore, 2004). About 70 percent of orofacial 
clefts arise as an isolated form where no other anomalies are associated in those patients, 
while the remaining cases occur in syndromes; about 400 syndromes are known to cause 
orofacial clefts (Zucchero et al., 2004). Recent studies show that genes causing syndromic 
CL/P have a significant overlapping etiology with non-syndromic clefting (Stanier and 
Moore, 2004). Studying those genes and related molecular pathways will help us further 
understand pathogenesis of human facial clefts.  
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In addition to genetic factors associated with orofacial clefts, numerous non-
genetic risk factors have been identified. Maternal smoking during periconceptional 
period increased incidence of CL/P and CP by twofold (Honein et al., 2007). Smoking 
during pregnancy also increases the chance of causing orofacial clefts in fetuses with 
certain susceptibility loci (Lammer et al., 2004). In addition, the Food and Drug 
Administration (FDA) recently announced that certain types of antiepileptic medications 
increase the risk of CL/P and CP.  
  18 
 
 
Figure ‎1.6: Types of cleft palate and cleft lip. 
Normal palate morphology and types of cleft palate. The palate is composed of 
the primary palate and secondary palate. The secondary palate is further subdivided 
into the hard palate and the soft palate. The degree of severity varies case by case, some 
only affect the soft palate while others affect both the secondary and primary palates as 
well as lip formation. 
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1.2.4 Mandibular development 
The mandible develops through unique steps. Bilaterally symmetric mandibular 
buds of PA1, stuffed with mesenchymal NCCs and paraxial mesoderm and enclosed by 
endodermal and ectodermal epithelial layers, dramatically grow and fuse to each other 
at the midline (Chai et al., 2000b). Within this fused mandibular process arises Meckel’s 
cartilage (MC), a rod-shaped transient structure that functions as a template for 
mandibular formation. NCCs surround MC to form a membranous sheath, which later 
undergoes intramembranous ossification to form the mandible proper (Fig. 1.7). The 
distal portion of MC undergoes endochondral ossification to become a part of the 
mandibular bone supporting the incisors, whereas the proximal portion contributes to 
the inner ear ossicles. The central part of MC disappears soon after birth (Frommer and 
Margolie.Mr, 1971).  MC degradation may be induced by feed-forward secretion of 
interleukin-1β by infiltrating macrophages and chondrocytes (Tsuzurahara et al., 2011).  
Proper mandibular morphogenesis requires signaling interactions between 
mesenchyme and epithelial cells in PA1. In addition, signaling from pharyngeal 
endoderm plays a significant role in mandibular growth. Survival of mesenchyme, 
Meckel’s cartilage outgrowth and osteogenesis of mandibular bones are closely 
regulated by stage-and region-specific roles of BMP and FGF signaling pathways (Mina 
et al., 2007; Mina et al., 2002; Wilke et al., 1997). For example, ectopic BMP4 application 
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to mandibular explants increases apoptosis and represses Fgf8 transcription. Fgf8 
signaling is considered as a source of survival signaling for mesenchyme in PA1. Mouse 
embryos lacking the BMP antagonists Chordin and Noggin show reduced Fgf8 in the 
pharyngeal ectoderm and increased apoptosis, resulting in a whole spectrum of 
mandibular outgrowth defects (Stottmann et al., 2001).  Perturbing FGF receptor 3 
(FGFR3) in Meckel’s cartilage before chondrogenic and osteogenic condensations results 
in defects in development of the mandibular process and Meckel’s cartilage and a lack of 
mandibular bones (Mina et al., 2007). 
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Figure ‎1.7: Meckel’s cartilage and mandibular development 
(A) chondrocyte condensation begins in the mandibular process between E11.5 
and E12.5. (B) “V” shaped Meckel’s cartilage forms around E13.5. (C) Meckel’s cartilage 
elongates in proximal-distal direction and osteogenesis begins at E14.5. (D) Ossification 
progresses around Meckel’s cartilage using Meckel’s cartilage as a template at E16.5.  
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1.2.5 Micrognathia 
Micrognathia, characterized by mandibular hypoplasia, is another example of a 
common craniofacial structural malformation. It is generally considered a defect in 
which too few NCCs populate PA1, due to insufficient production or migration during 
the fourth week of human gestation. Such NCC defects are often caused by 
misregulation of signaling pathways elicited by genetic and environmental factors. 
Affected patients show a wide range of malformation, from almost normal to agnathia, a 
complete lack of the lower jaw. While multiple syndromes include micrognathia, 
isolated micrognathia may cause sequential deformities. Hypoplastic mandible can 
displace the tongue posteriorly, which in turn prevents elevation of palatal shelves, 
leading to CP or CL/P as in Pierre Robin sequence (Weseman, 1959). Children with 
micrognathia often have problems of feeding and upper airway breathing as well as 
sleep apnoea.  In severe cases, surgical intervention may be required to allow the 
mandibular bone to elongate (Figueroa, 2002). Although it has been believed that in 
some cases of mandibular hypoplasia, outgrowth may eventually attain normal 
proportions during childhood, recent findings suggest the underdeveloped mandible 
generally remains small (Daskalogiannakis et al., 2001; Suri et al., 2010). 
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1.2.6 Development of the neurocranium 
The neurocranium is composed of two parts: the skull vault and the base. The 
skull vault consists of multiple separate membranous bones - frontal, parietal, and a part 
of the occipital bones. The frontal bones are derived from NCCs, while others are mostly 
derived from mesoderm cells (Jeong et al., 2004; McBratney-Owen et al., 2008). 
Connective tissues called cranial sutures articulate these bones, resulting in formation of 
fontanelles at the boundaries of cranial bones (Fig.1.8A). These sutures are the primary 
sites of osteogenesis during skull development. Cranial sutures are formed between 
neighboring membranous bones when cells at the osteogenic front proliferate. Tissue 
and molecular signaling interactions with underlying dura mater influence development 
and maintenance of cranial sutures.  Dura mater releases and takes up cytokines, 
mediates biochemical signaling and contributes cells to suture mesenchyme. FGFs are 
expressed in dura mater just below the forming sutures; FGF signaling is critical for 
cranial suture biology (De Coster et al., 2007; Ogle et al., 2004). Maintenance of suture 
patency at birth helps the skull of a baby go through the birth canal and, until 12-18 
months, is essential for proper brain growth and development (Richtsmeier et al., 2006).  
The skull base includes midline structures such as the ethmoid, sphenoid, 
basioccipital bones, and parts of the temporal bones. These bones play an important role 
in supporting the brain. The anterior-most skull base is derived from NCCs, while the 
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posterior skull base is derived from paraxial mesoderm (Couly et al., 1993). The timing 
of growth, ossification and maturation of the anterior and posterior skull base is not 
synchronous. A distinct feature of skull base bones is that, unlike other craniofacial 
skeletal elements, these bones develop through endochondral ossification. The skull 
base first forms from multiple paired cartilaginous anlagen from caudal to rostral. These 
grow, extend and fuse together resulting in formation of skull base sutures between each 
cartilaginous element. Eventually, they form a single perforated base plate.      
Chondrogenesis in neural crest derived cartilages requires Sox9. Mesoderm-derived 
occipital bone is present while NCC-derived sphenoid bone is absent in mice lacking 
Sox9 (Mori-Akiyama et al., 2003). The development of the skull base is also critical for 
facial growth. The size and shape of the skull base affect the position of mandible, and 
may cause consequential craniofacial deformities such as CP (Bastir et al., 2010; Harris, 
1993; Lieberman et al., 2000; Nie, 2005). 
1.2.7 Craniosynostosis and skull base deformities 
Premature suture fusion, craniosynostosis, occurs 1 in 2500 human births (Cohen 
and MacLean, 2000) (Table 1.2). The form of craniosynostosis depends on the affected 
suture(s) (Fig.1.8B). Nature of the alteration in cranial vault shape depends on which 
sutures are fused prematurely. Different types of craniosynostosis involve distinct 
etiology. Primary craniosynostosis is caused by premature ossification of the skull vault, 
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and union of one or more cranial sutures. Accordingly, abnormal shape of the cranial 
vault and/or premature closure of the fontanelles result. In contrast, secondary 
craniosynostosis is caused by insufficient brain growth, that is usually caused in turn by 
failure of cephalic neural tube closure in the first month of human embryonic 
development. More than 180 syndromes include craniosynostosis in humans, including 
Apert, Crouzon, and many others (Hennekam and Van den Boogaard, 1990) (Table 1.2). 
Mutations in FGFs, genes involved in FGF signaling, and the osteogenic transcription 
factor Runx2 have been identified as the molecular lesions underlying syndromes with 
craniosynostosis (Kimonis et al., 2007).  
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Table ‎1.2: Syndromes with craniosynostosis and implicated genes. 
Gene Syndromes 
Fgfr1 Jackson-Weiss syndrome, Kallmann syndrome2, Pfeiffer syndrome 
 
Fgfr2 Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, LADD syndrome,     
Saethre-Chotzen syndrome 
 
Fgfr3 Crouzon syndrome, LADD syndrome, Muenke syndrome 
 
Twist1 Saethre-Chotzen syndrome 
 
Fbn1 Marfan syndrome, MASS syndrome 
 
Tgfbr1 & Tgfbr2 Loeys-Dietz syndrome 
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The frequency of deformities in the skull base is less than that of defects in other 
parts of the craniofacial skeleton. The NCC-derived anterior skull base is more 
susceptible to defects than the posterior mesoderm-derived skull base (Nie, 2005). 
Abnormalities of the skull base can affect the position of the jaws. A recent study has 
suggested correlations between anterior skull base morphology and midfacial retrusion 
(Lozanoff et al., 1994). Some cases of skull base deformities are also observed in the 
syndromes causing craniosynostosis (Nie, 2005). Research so far has been unable to 
conclude if skull base abnormalities are the cause or consequences of craniosynostosis or 
craniofacial deformities. Defects in the skull base are often observed in skull base sutures 
and cartilage growth plate called synchondroses. The location and timing of premature 
skull base fusion and synchondroses can influence the craniofacial symmetry of a child. 
Premature skull base closures and abnormal growth in synchondroses are recognized in 
many syndromes such as Crouzon and Apert (Goodrich, 2005). However, as Goodrich 
suggests, the development of each unit, the skull vault, facial skeleton, and the skull 
base influences the other units of the head skeleton. Thus, it is critical to maintain proper 
regulation of gene expression, tissue growth, and patterning for development of 
craniofacial skeletal elements.  




Figure ‎1.8: Cranial sutures and types of craniosynostosis viewed from above.  
 (A) Positions of the major cranial sutures. (B) Diagnostic features of 
craniosynostosis.  Sagittal synostosis results in a long and narrow head.  Right unilateral 
coronal synostosis shows flattened forehead on affected side. Bilateral coronal synostosis 
causes flattened head. Metopic synostosis dysplays hypotelorism and pointy forehead. 
Lamboid synostosis causes a flattening of the back of the head. 
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1.3 Development of neural tube 
Neural tube is the dorsally located epithelial tubular structure found in the early 
vertebrate embryo. Neural tube is originated from the neural ectoderm and the 
precursor to the central nervous system. Mammalian neural tube first develops from a 
flat sheet called the neural plate.  The neural plate will turn into the neural tube through 
two major events; primary neurulation and secondary neurulation. Primary neurulation 
during which the brains and most part of spinal cord form occurs rostrally to future 
sacral level of the spine (Copp et al., 1989). Secondary neurulation occurs more caudally 
by condensation and epithelialization of mesenchymal cells to form the sacral and all of 
the coccygeal regions of the spinal cord. In primary neurulation, cells in the neural plate 
elongate and both edges of the neural plate elevate to form the medial hinge point 
(MHP) right above the notochord and the neural folds at the lateral sides of the neural 
plate. Because of its distinct mechanism of development, the lower spinal neural tube 
that is derived through secondary neurulation does not have MHP. In addition to MHP, 
formation of dorsolateral hinge points (DLHPs) is critical in certain parts of neural tube 
including intermediate spine and cranial neural tube (Fig. 1.9). In addition to proper HP 
formation, neural tube closure involves adhesion and fusion of epithelial sheets.  
Convergent extension of the neural folds allows midline epithelium of the apposing 
neural folds to happen, resulting in hollow tube formation.  
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Figure ‎1.9: Neural tube development 
(A) Neural induction begins in the flat neural plate. (B) MHP (black arrow head) 
forms at the future midline of the body. (C) Both sides of the neural plate elevate 
dorsally to form the neural fold. (D, E) DLHP (black arrow heads) formation allows 
neural folds to juxtapose to each other. (F) The neural folds meet at the dorsal midline to 
fuse, completing neural tube closure. 
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1.3.1 Human neural tube defects and animal models of studying NTDs 
Neural tube defects (NTDs) are one of the most common congenital deformities 
in humans. Every year, approximately 300,000 babies are born with NTDs (Botto et al., 
1999). Since the report of folic acid effectiveness by the Medical Research Council 
Vitamin Study Group was released in 1991, many countries have recommended 
periconceptional intake of folic acid. Moreover, improved technologies such as high-
resolution ultrasonography for in utero fetal examination, and termination of affected 
pregnancies also have helped reduce the prevalence of NTD considerably (Kondo et al., 
2009). However, according to the International Clearinghouse for Birth Defects 
Surveillance and Research, among G8 countries (8 developed countries), Germany and 
Japan exceed the average rate of prevalence -approximately 3 to 4 per 10,000 live births 
and stillbirths with or without termination of pregnancy between 2000 and 2004. There 
are several reasons to explain this result. First, accuracy of the diagnosis may differ from 
a country to country. Second, public awareness of importance of periconceptional 
consumption of folic acid for preventing NTDs may be lower in some countries. In 
addition, folic acid may not be effective to prevent all the NTDs because etiology of 
NTDs may be diverse. It is critical to understand etiology of different types of NTDs to 
prevent this serious human health problem.  
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Studies using animal models such as zebrafish and mice have contributed to 
identify mechanisms underlying the NTDs. In human, variants of VANGL1, a planner 
cell polarity gene, are associated with NTDs. Two variants were tested in zebrafish and 
led to defective convergent extension phenotype. Thus, this study demonstrates 
conserved function of the gene that causes NTDs and zebrafish as a useful animal 
model. Mouse studies concerning NTDs also have been extensively carried out and 
provided valuable insight for us to understand genetic, cellular and molecular 
mechanisms of NTDs.  
1.3.2 Mechanisms of HP formation and neural tube closure 
Neural tube closure involves a sequence of dynamic cellular change in the neural 
plate. The key event of neural tube closure is formation of hinge points. There are two 
types of hinge points in neurulation, MHP and DLHPs (Fig. 1.9). MHP and DLHPs have 
distinct roles in neural tube closure at different levels of spinal axis in mice (Shum and 
Copp, 1996). First hinge point, MHP, appears at the center of the neural plate, dividing 
future left and right. MHP is the only HP required in the upper spinal region of the 
neural tube (Ybot-Gonzalez et al., 2002). Induction from the notochord is critical for 
MHP formation (Smith and Schoenwolf, 1989). The coordinated morphogenesis of 
epithelial tubing has been implicated in active regulation of apicobasal epithelial 
polarity (Andrew and Ewald, 2010). Upon induction from the notochord, cells in the 
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neural plate where the notochord is apposed elongate along an apicobasal direction and 
become columnar from cuboidal and then transform into wedge-shaped, which in turn 
form MHP and the neural groove, while adjacent cells in the neural plate maintain their 
spindle-shape (Schoenwolf and Franks, 1984). To accomplish cell elongation, 
centrosomal microtubule consisting of alpha- and beta-tubulin, one of the major cell 
cytoskeleton, plays an important role. Randomly oriented microtubules mainly around 
cell cortex in the columnar cells polymerize and assemble, while non-centrosomal 
gamma-tubulin is localized apically in the cells undergoing apicobasal elongation (Lee et 
al., 2007). Interestingly, Shroom3, which was previously identified to cause NTD when it 
was mutated, is an actin binding protein and was reported to recruit gamma-tubulin to 
the apical region in the Xenopus neural tube (Haigo et al., 2003; Lee et al., 2007). Another 
study suggests that Shroom3 regulates neuroepithelial apical constriction through 
recruitment of ROCK1 to the apical junctions, which leads to phosphorylation of Myosin 
light chain (MLC) required for actomyosin contraction (Nishimura and Takeichi, 2008). 
Recent studies in chick show that the shape change of the cells in the MHP of the 
midbrain neural tube are regulated by a dynamic modulation of cell behaviors, namely 
apical constriction and basal nuclear migration closely regulated by BMP signaling (Eom 
et al., 2011; Eom et al., 2012). According to their model, in the presence of canonical BMP 
signaling, pSmad interacts with the PAR3-PAR6-aPKC that is associated with the apical 
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tight junctions, while local inhibition of BMP in the cells at the presumptive MHP 
destabilize apical PAR complex, disrupting tight junction. This allows apical localization 
of LGL, resulting in apical constriction and basal nuclear migration. However, it is still 
unknown if cellular and molecular mechanisms found in MHP formation are applicable 
to DLHP formation (Eom et al., 2011; Eom et al., 2012).  
The other HPs are paired DLHPs which appear at the junction between the 
neural ectoderm and surface ectoderm. Bending of DLHPs allows both sides of neural 
folds to juxtapose to each other (Fig. 1.9D). This allows neural tube fusion to occur. As 
MHP receives induction from the notochord, induction from non-neural surface 
ectoderm is required to form DLHPs (Ybot-Gonzalez et al., 2002). The members of 
Grainy head-like (Grhl) family of developmental transcription factors, Grhl2 and Grhl3 
are expressed in non-neural ectoderm. In mice, ablating Grhl2 causes a split face and 
exencephaly, while loss of Grhl3 results in spina bifida in the lower spine. In both cases, 
the phenotypes were associated with defective DLHP formation (Rifat et al., 2010). 
Cytoskeletal rearrangement is also important for DLHP formation. Members of zinc-
finger transcription factors, zic2a and zic5 are expressed at the border of future DLHPs. 
Zic2a and zic5 are the downstream targets of the canonical Wnt signaling pathway 
(Nyholm et al., 2007). Loss of zic2a and zic5 by morpholino treatment causes a defect in 
DLHP formation due to lost apical junction integrity with disrupted actomyosin 
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organization in zebrafish (Nyholm et al., 2009). Interestingly, Zic2 mutant mouse 
embryos lack dorsal BMP antagonist expression and DLHP formation, resulting in 
severe spina bifida (Ybot-Gonzalez et al., 2007b). Although these studies suggest that 
similar molecular and cellular mechanisms in DLHP formation found in zebrafish also 
regulate mouse DLHP formation, further study is still required. Hh signaling is another 
important signaling pathway in neurulation. BMP signaling and Hh signaling often 
antagonize each other in multiple different contexts such as neural fate specification in 
the early neural tube. In neurulation, Shh acts as a negative regulator of Noggin (Nog) 
(Ybot-Gonzalez et al., 2007). Shh is expressed ventrally in the notochord. However, the 
strength of Shh expression correlates with the presence or absence of DLHPs along the 
spinal axis. Hh signaling inhibits DLHP formation by antagonizing dorsal genes such as 
Nog. Its expression is markedly weaker at the lower spinal levels where DLHPs are 
formed (Ybot-Gonzalez et al., 2002). However, detailed cellular and molecular 
mechanisms of how Hh signaling prevents DLHP formation remain unclear.  
The final step in neural tube closure is contact and fusion of epithelium, which 
are observed in many other morphogenetic events such as palatal shelves and eyelids. 
This step is followed by more stable union and epithelial remodeling. During neural 
tube closure, first contact of apposing neural folds is initiated by cellular protrusions 
comprising of lamellipodia and filopodia. Deleting Ena/VASP, which regulate 
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lamellipodia and filopodia, resulted in exencephaly (Furman et al., 2007). Surprisingly, 
there is not much information about requirement of adhesion molecules in fusing neural 
tube. However, it is likely that combination of initial contact by cellular protrusion and 
molecular adhesion from apposing neural epithelium induce following epithelial 
remodeling, ensuring fusion and neural tube closure. Further studies of this area will be 
awaited.   
The final step in neural tube closure is contact and fusion of epithelium, which 
are observed in many other morphogenetic events such as palatal shelves and eyelids. 
This step is followed by more stable union and epithelial remodeling. During neural 
tube closure, first contact of apposing neural folds is initiated by cellular protrusions 
comprising of lamellipodia and filopodia. Deleting Ena/VASP, which regulate 
lamellipodia and filopodia, resulted in exencephaly (Furman et al., 2007). Surprisingly, 
there is not much information about requirement of adhesion molecules in fusing neural 
tube. However, it is likely that combination of initial contact by cellular protrusion and 
molecular adhesion from apposing neural epithelium induce following epithelial 
remodeling, ensuring fusion and neural tube closure. Further studies of this area will be 
awaited. 
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1.4 BMP signaling  
Bone morphogenetic proteins (BMPs) are a group of secreted proteins that 
belong to transforming growth factor beta (TGF-beta) superfamily. BMPs consist of 
more than 15 ligands in mammals. While BMPs were first identified as bone/cartilage-
inducing molecules, later studies found BMP signaling acts in organogenesis and 
maintenance of many tissues and organs, especially in dorsoventral and/or antero-
posterior patterning formation. Homo- or hetero-dimers of BMP ligands bind to and 
signal through their receptors to induce expression of downstream target genes 
influencing cell proliferation, survival, and differentiation. BMP signaling pathway is 
evolutionally conserved and critical for multiple stages of embryogenesis and tissue 
homeostasis. 
BMP signaling intensity is regulated by multiple mechanisms. One of the most 
important concepts is so called “sink-source model”. BMPs act as morphogens that 
diffuse from and travel away from the cells in which they are synthesized (source), 
creating morphogen gradient. In a simple model, the morphogen gradient directly 
correlates with the level of BMP signaling. However, BMP signaling is also regulated by 
other players in the signaling pathway. BMP inhibition by antagonists, such as Nog, 
ensures the level of BMP signaling required for proper development or maintenance of 
the tissues and organs. Nog, a major BMP antagonist, binds to BMPs in the extracellular 
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space, and prevents them from binding to their own receptors (Fig. 1.10). In contrast, 
inhibin and BMP3 are the BMP receptor antagonists; they bind to BMP receptors instead 
of binding to ligands to block BMP signaling. Level of BMP receptor expression also 
affects intensity of BMP signaling. As such, fine tune of BMP signaling is assured by 
multiple mechanisms.  
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Figure ‎1.10: Canonical BMP signaling and gradient formation 
BMPs (pink) are a secreted molecule in the extracellular space. They bind to and 
signal through the receptors at the cell surface. Binding BMPs to their receptors causes 
phosphorylation to Smads, and translocation of pSmads to the nucleus, resulting in 
transcription of downstream target genes. Nog (green) is also a secreted molecule. Nog 
inhibits BMP signaling transduction by binding to BMPs in the extracellular space, 
preventing BMPs from binding to their receptors. Nog antagonism is important for 
creating the BMP gradient, which is critical in multiple processes during embryonic 
development.  
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1.4.1 BMP signaling pathways 
Among BMP ligand-activated signaling pathways, Smad pathway is the most 
well studied pathway. Both classes of transmembrane receptors, type I and type II, are 
required for BMP signaling transduction. Upon binding of BMPs to heterotetrameric 
complex of type I and type II receptors, type II receptor kinase phosphorylates the type I 
receptor, which in turn phosphorylates receptor Smad 1/5/8 (R-Smads).  Phosphorylated 
Smad 1/5/8 form complexes with co-Smad (Smad4), which translocate into the nucleus 
and induce downstream target gene expression. Phosphorylated Smad 1/5/8 is often 
used as a readout for BMP signaling activity. Smad6 and Smad7 (I-Smads) act as 
antagonists of Smad signaling pathway by binding to type I receptors and prevent 
activation of R-Smad. Expression of I-Smads is regulated by R-Smads, creating a 
negative feedback loop.  
In addition to the canonical Smad signaling pathway explained above, BMPs 
activate multiple kinase signaling pathways, including p38 and Erk MAP kinase, PI3, 
and PKC pathways (Kishigami and Mishina, 2005; Xu et al., 2008). Both canonical BMP 
signaling (Smad4) and p38 MAP kinase are activated in mediating TGF-beta/BMP 
signaling during tooth and palate development (Xu et al., 2008). These signaling 
pathways induce cell proliferation and differentiation.   
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1.4.2 Nog, a BMP antagonist in development 
Nog is a secreted molecule that is encoded by the single-exon Nog gene. It was 
first discovered as a neural inducer in Xenopus (Smith and Harland, 1992). It is 
evolutionally conserved. Nog’s function as a BMP antagonist was confirmed in 
evolutionally primitive species such as hydra. When Nog mRNA isolated from hydra 
was microinjected into Xenopus embryos, a secondary dorsoventral body axis 
developed (Chandramore and Ghaskadbi 2011). Contrary to expectation, Nog is not 
found in Drosophila melanogaster (Holley et al., 1996). Nog acts as a BMP antagonist by 
binding to BMPs in the extracellular space and masking the epitopes that are important 
for BMPs to bind to their cell surface receptors for activating downstream target genes. 
In addition to Nog’s role as a BMP antagonist, it is found that Nog can bind to non-BMP 
TGF-beta ligands and XWnt8 and inhibit Activin/Nodal and Wnt signaling in Xenopus 
embryos during forebrain development (Bayramov et al., 2011). Nog may regulate non-
BMP signaling pathways in mammals.  
Early Nog expression also plays an important role in left-right axis establishment 
during somitogenesis stages. Nog regulates expression of Nodal that is a critical left-side 
determinant in the node and lateral plate mesoderm (Mine et al., 2008). Proper left-right 
set-up at this stage is crucial for subsequent morphogenesis and alignments of organs.  
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Importance of Nog in the skeletogenesis has been extensively studied. Nog 
mutations in humans are found in association with several dominant autosomal 
syndromes due to haploinsufficiency of the gene dosage. Affected individuals manifest 
skeletal defects and synostoses such as symphalangism, craniofacial defects and stapes 
fixation (Rudnik-Schoneborn et al., 2010; Hwang and Wu, 2007). Mouse studies revealed 
that Nog heterozygous mice exhibit conductive hearing loss similar to human patients 
with Nog mutations. The conductive hearing loss was caused by a synostosis between 
the stapes and styloid process resulting from ectopic bone formation during 
development (Hwang and Wu, 2007). Nog null mice show multiple craniofacial 
deformities including cleft palate and micrognathia (Stottmann et al., 2006; He et al., 
2010). We will discuss more details about Nog’s role in development of craniofacial 
skeletogenesis in a later chapter. Other roles of Nog during development are found in 
skeletal muscle generation (Smith and Harland, 1992) and differentiation of hair follicles 
(Botchkarev et al., 1999). 
1.4.3 BMP signaling and Hh signaling in development 
BMP signaling is involved in the most cellular processes throughout the life of an 
organism. One reason that BMP signaling can cause different cellular processes is 
signaling cross-talk in which BMP signaling together with other signaling creates 
distinct cellular responses. Depending on the partner signaling, the signaling cross-talk 
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gives diverse outcomes. One of such partner signaling pathways is Hh signaling. Like 
BMP signaling, Hh signaling is also involved in various types of cellular processes 
including cell proliferation and survival.  
 Hh signaling was first identified in Drosophila embryonic patterning, and now 
it has been known as one of the key signaling pathways in the development of 
multicellular organisms. Genetic studies in different organisms revealed most of the 
components in Hh signaling pathway are highly conserved throughout the species. Hh 
ligands consist of three secreted lipid molecules, Sonic hedgehog (Shh), Indian hedgehog 
(Ihh), and Desert hedgehog (Dhh) in chick and mammals.  
Cross-talk between BMP signaling and Hh signaling is highly context dependent. 
They work together synergistically or antagonistically. Importantly, BMP and Hh 
signaling pathways can directly regulate each other by binding to the promoter region of 
key factors of each other (Zhao et al., 2006; Guo and Wang 2009). In vitro study suggests 
that Gli activates human BMP4 and BMP7 gene promoters (Kawai and Sugiura, 2001). 
Smads modulates Hh signaling through regulation of Gli transcription directly or 
indirectly (Rios et al., 2004; Alvarez-Rodriguez et al., 2007). 
In vivo studies support the interactions between BMP and Hh signaling in 
several developmental contexts. Disrupted Shh signaling in the ventral neural tube of a 
mouse with cilia defects causes abnormal dorsal neural tube patterning due to aberrant 
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BMP signaling (Honer and Caspary, 2011). In humans, SATB2 causes severe palatal and 
mandibular defects. The expression of satb2 in pharyngeal arches is mediated by both 
BMP signaling and Hh signaling in zebrafish (Sheehan-Rooney et al., 2013). BMP4 
expression in the palatal mesenchyme is required for Shh expression in the medial edge 
epithelium (MEE) for proper anterior palatal shelf growth and development (Zhang et 
al., 2002). 
Taken together BMP and Hh signaling pathways are highly interdependent in 
various cellular processes. Therefore, studying mutation of one signaling pathway often 
finds disruption of the other.
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2. Multiple tissue-specific requirements for the BMP 
antagonist Noggin in development of the mammalian 
craniofacial skeleton 
 
The following chapter is currently under review for publication.  
 
Proper morphogenesis is essential for both form and function of the mammalian 
craniofacial skeleton that consists of more than twenty small cartilages and bones. 
Skeletal elements that support the oral cavity are derived from cranial neural crest cells 
(NCCs) that develop in the maxillary and mandibular buds of pharyngeal arch 1 (PA1). 
Bone Morphogenetic Protein (BMP) signaling has been implicated in most aspects of 
craniofacial skeletogenesis, including PA1 development. However, the roles of the BMP 
antagonist Noggin in formation of the craniofacial skeleton remain unclear, in part 
because of its multiple domains of expression during formative stages. Here we used a 
tissue-specific gene ablation approach to assess roles of Noggin (Nog) in two different 
tissue domains potentially relevant to mandibular and maxillary development. We 
found that the axial midline domain of Nog expression is critical to promote PA1 
development in early stages, necessary for adequate outgrowth of the mandibular bud. 
Subsequently, Nog expression in NCCs regulates craniofacial cartilage and bone 
formation. Mice lacking Nog in NCCs have an enlarged mandible that results from 
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increased cell proliferation in and around Meckel’s cartilage. They also show complete 
secondary cleft palate, most likely due to inhibition of posterior palatal shelf elevation 
by disrupted morphology of the skull base structure. Our findings demonstrate multiple 
roles of Nog in different domains for craniofacial skeletogenesis, and suggest a novel 
mechanism of secondary cleft palate that previous studies have not revealed. 
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2.1 Introduction 
Among the most frequently occurring congenital defects in newborns are 
craniofacial deformities, such as cleft palate and micrognathia (Holder-Espinasse et al., 
2001; Mossey PA, 2002). These malformations impact the quality of life due to functional 
difficulties as well as negative social responses (Pruzinsky, 1992). The causes of 
craniofacial deformities are diverse, including genetic and environmental factors. Yet the 
underlying genetic and cellular mechanisms behind the emergence of such deformities 
are not well understood.  
Mammalian craniofacial skeletal elements consist of more than 20 small bones 
and cartilages, the size and shape of which are precisely determined during 
development (reviewed by (Matsui and Klingensmith, 2013). Most of these skeletal 
elements are derived from neural crest cells (NCCs), an ectoderm-derived multipotent 
cell population that migrates ventrally from the closing dorsal neural folds. NCCs take 
distinct migratory pathways, with some populating the pharyngeal arches. One such 
group of NCCs populating pharyngeal arch 1 (PA1) proliferates, differentiates and gives 
rise to most of the frontal facial structures such as Meckel’s cartilage, the mandible and 
the maxilla including the bones of the palate. Although NCCs possess intrinsic 
information that promotes differentiation of the facial skeleton, interactions between 
NCCs and other tissues such as ectoderm or endoderm allow molecular signaling 
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between tissues to ensure proper morphogenesis and development of pharyngeal arch 
derivatives (Couly et al., 2002).  
Bone morphogenetic protein (BMP) signaling has been implicated as a key 
regulator of development of NCCs and their derivatives (Baek et al., 2011; Bonilla-
Claudio et al., 2012; Dudas et al., 2004; Goldstein et al., 2005; Kanzler et al., 2000). Mouse 
genetic manipulation studies revealed a requirement for precise regulation of BMP 
signaling in craniofacial development (Bonilla-Claudio et al., 2012; Li et al., 2013; Wang 
et al., 2013). 
One important means of regulating BMP signaling is by extracellular BMP 
antagonists. Nog is a major BMP antagonist expressed in multiple domains during 
embryonic development. Noggin binds to BMP ligands in the extracellular space and 
prevents them from binding their receptors. Experimental work in mice indicates that 
Nog regulates various types of skeletogenesis, including appendicular bone, cartilage 
and joint formation (Brunet et al., 1998). Genetic studies in humans have also identified a 
role for Nog in regulating skeletal morphogenesis, with mild ectopic bone formation 
particularly in the digits, associated with heterozygous loss-of-function mutations 
(reviewed by (Potti et al., 2011).  
As demonstrated primarily by analysis of the null phenotypes of mice lacking 
the Nog gene, this BMP antagonist also has important roles in regulating the 
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development of craniofacial structures (He et al., 2010; Stottmann et al., 2001; Stottmann 
et al., 2006; Wang et al., 2013). In postnatal stages of development, Nog expression in 
cranial sutures prevents the premature fusion of skull bones (craniosynostosis) (Warren 
et al., 2003). Nog null mice display cleft palate, a defect ascribed to compromised 
integrity of palatal epithelium due to the change in cell death and cell proliferation rate 
(He et al., 2010). Further roles of Noggin are betrayed in the absence of Chordin, another 
BMP antagonist which when lacking on its own has only very mild, non-lethal 
phenotypes (Choi and Klingensmith, 2009). Mice lacking one or both alleles of Nog 
display a range of craniofacial malformations of varying expressivity and penetrance. 
These sometimes include dramatic truncations of the rostral head, in association with 
holoprosencephaly (Anderson et al., 2002; Bachiller et al., 2000). These defects are due at 
least in part to defective Shh signaling from the prechordal plate and Fgf8 signaling 
from the anterior neural ridge, organizing centers of early forebrain patterning and 
growth (Anderson et al., 2002).  
Independent of this early rostral requirement, these BMP antagonists also 
function to promote mandibular development. Whereas mice lacking the Chordin gene 
(Chrd) show a very low penetrance of mild micrognathia (Choi and Klingensmith, 2009), 
Chrd-/-;Nog+/- and Chrd-/-;Nog-/- exhibit a spectrum of mandibular hypoplasia, ranging from 
agnathia to micrognathia, as a result of insufficient NCC survival during mandibular 
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bud outgrowth PA1 (Stottmann et al., 2001). In contrast, in the absence of Nog alone, 
mandibles are enlarged, reflecting increased size of the transient Meckel’s cartilage, 
around which mandibular bone is formed (Stottmann et al., 2001; Wang et al., 2013). The 
mandible forms via ossification of cells from the NCC-derived perichondrium at the 
periphery of Meckel’s cartilage, which itself is composed of both neural crest derivatives 
and other mesenchymal cells (Chai et al., 2000a). Whereas the normal fate of 
chondrocytes in the main portion of Meckel’s cartilage is to degenerate, in Nog mutants 
or in embryos expressing an activated BMP receptor transgene in chondrocytes, these 
cells over-proliferate, then differentiate and undergo ossification (Wang et al., 2013).  
These phenotypes all reveal important roles for Nog in regulating development 
of the craniofacial skeleton, but the relevant spatiotemporal contexts of Nog expression 
are not clear for any of these roles. During early stages of head development, Nog is expressed 
in several potentially relevant domains (Anderson et al., 2002; He et al., 2010; Lana-Elola et al., 
2011; Nifuji and Noda, 1999; Stottmann et al., 2001). Here we further probe the expression 
of Nog in relation to development of the viscerocranium. We then use a series of tissue-
specific ablations of the Nog gene to elucidate the cellular mechanisms of Noggin 
function in mandibular and palatal development. 
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2.2 Materials and Methods 
2.2.1 Mouse strains  
The Nogfx/fx conditional (Stafford et al., 2011), NoglacZ/+ (Brunet et al., 1998), and 
constitutively active Bmpr1a conditional mice (caBmpr1a), conditional mice were 
maintained on the mixed background. Wnt1-Cre mice (Brewer et al., 2004; Chai et al., 
2000b; Jeong et al., 2003; Jiang et al., 2000) were crossed with Noglacz/+ to generate Wnt1-
Cre;Noglacz/+ male mice, which were subsequently crossed with Nogfx/fx to conditionally 
knockout Nog from neural crest cells. As a complement experiment, caBmpr1a, which 
have been described previously (Rodriguez et al., 2010), were crossed with Wnt1-Cre to 
activate BMP signaling only in NCCs.   
2.2.2 Histology, immunohistochemistry, and X-gal staining 
For histology, embryos were harvested from pregnant mice, fixed in 4% 
paraformaldehyde (PFA) at 4°C for 2 hours to overnight depending on gestation stage, 
dehydrated through graded alcohols, embedded in paraffin wax and sectioned at 10-um 
thickness. The sections were stained with hematoxylin and eosin for morphological 
observations.  
Whole embryos are stained with X-gal overnight at RT. For section X-gal 
staining, embryos were fixed 2 hours to overnight embedded in OCT compound (Sakura 
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Finetek) after sucrose gradient (15% and 30% sucrose in PBST). Cryosections were made 
at 10 um thickness and stained with X-gal.   
2.2.3 Skeletal preparations and in situ hybridization 
For skeletal preparation, embryos were skinned, fixed in 95% ethanol overnight, 
stained with 0.05% alcian blue, washed in 95% ethanol for 6hours to overnight and 
cleared in 2% KOH. Further, to stain bone, embryos were placed in 0.005% alizarin red 
in 0.9 N acetic acid and 60% ethanol overnight at room temperature and cleared with 1% 
KOH for overnight followed by 20% glycerol in 1% KOH until cleared. For whole mount 
in situ hybridization, embryos were dissected from pregnant mice, fixed overnight in 4% 
PFA at 4°C. The fixed embryos were dehydrated through 25%, 50%, 75%, and 100% 
ethanol, and stored in 100% ethanol at -20°C. Whole mount in situ hybridization was 
carried out using previously described protocol (Belo et al., 1997) with hybridization 
temperature of 65°C. 
2.2.4 Palatal shelf organ culture 
Palatal shelves were cultured according to previously described methods (Brunet 
et al., 1995; Taya et al., 1999a). Palatal shelves were removed at E13.5 from wild-type and 
Wnt1-Cre;Noglacz/fx embryos. Paired palatal shelves were placed on 0.3 um Millipore filters 
with medial edge epithelia (MEE) in contact. Initially, paired palatal shelves were 
cultured in Minimal Essential Medium with Earle’s salts and L-glutamine (Gibco) 
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supplemented with 1% anti-anti (Gibco) at 37°C in a 5% CO2 air environment. After 24 
hours culture the paired palatal shelves were submerged in DMEM with Earle’s salts 
and L-glutamine (Gibco) supplemented with 5% FBS for another 48 hours. After total 72 
hours of culture, paired palatal shelves were fixed in 4% PFA and processed for paraffin 
blocks and sectioned 10-um thickness as described above.  
2.2.5 Quantitative real-time reverse transcription-polymerase chain 
reaction (RT-PCR) 
RNA was purified from E12.5 and E13.5 palatal tissue or mandibles from wild 
type and mutant using Trizol reagents (Invitrogen). Following RNA extraction, cDNA 
was synthesized using iScriptTM cDNA Synthesis Kit (BIO RAD). Quantitative PCR 
amplifications were performed in a StepOnePlus real-time PCR machine (Applied 
Biosystems) using the SensiMixTM SYBR & Fluorescein Kit (Bioline). For each gene, the 
PCR reaction was carried out in triplicates and the relative levels of mRNAs were 
normalized to that of HPRT using the normalized expression method. Student’s t-test 
was used to analyze the significance of difference and a P-value less than 0.05 was 
considered statistically significant.  
2.2.6 Detection of cell proliferation  
For detection of cell proliferation in the palatal shelves, pregnant female mice 
were injected once intraperitoneally at gestational day 12.5 and 13.5 with BrdU Labeling 
Reagent (50μg/g body weight; Roche). 30 min after injection, embryos were dissected, 
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fixed with 4% PFA overnight at 4°C and embedded in paraffin for 10um-thickness 
coronal sectioning. To detect BrdU, rat anti-BrdU (1:500; Accurate Chemical & Scientific) 
was used. Following BrdU immunostaining, cell counts were recorded for each of the 
bilateral palatal shelves of matching areas of anterior secondary palate and of posterior 
secondary palate regions in the wild type and mutant samples. The cell proliferation rate 
was calculated as the number of the cell nuclei with BrdU labeling. Alternatively, mouse 
anti-phosphorylated histone H3 (1:500; cell signaling) was also used to detect dividing 
cells. Data were collected from at least three pairs of mutant and wild type littermates at 
each developmental stage. Students’ t-test was used to analyze the significance of 
difference and a P-value less than 0.05 was considered statistically significant. 
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2.3 Results 
2.3.1 Expression of Nog during formative craniofacial development 
To gain insight into its possible roles of Nog in development of tissues derived 
from PA1, we assessed its spatiotemporal expression using an assay for the expression 
of a lacZ reporter in the published Nog null allele (Anderson et al., 2002; Brunet et al., 
1998; McMahon et al., 1998). Nog is expressed transiently in migrating and post-
migratory NCCs from the earliest stages, with robust expression by at E8.5 (Fig. 2.1A, B). 
At E9.5 expression is observed in NCCs in PA1 (Fig. 2.1C). By E10.5, its expression is 
restricted in epithelium of PA1 (Fig. 2.1D). Over this timeframe Nog is also present in the 
notochord, the floor plate of the neural tube, the dorsal foregut endoderm (Fig. 2.1B, C), 
and the ventrolateral foregut endoderm in the laryngeal region. During palatal 
development, between E11.5 and E13.5, Nog is more strongly expressed in the palatal 
epithelium. Nog is also expressed in various cartilages; as previously observed (Wang et 
al., 2013), this includes Meckel’s cartilage from E12.5 and later (Fig. 2.1E, F). 
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Figure 2.1: Nog is expressed in multiple domains during craniofacial 
development. 
(A, B) Nog is first expressed in the migrating NCCs around E8.0. (C) Nog is 
expressed in the NCCs of BA1. (D) By E10.5 Nog expression is restricted to the oral 
epithelium of BA1. (E, F) Nog is expressed in the cartilages in the head. pa1; pharyngeal 
arch 1, fp; floor plate of the neural tube, mc; Meckel’s cartilage, nccs; neural crest cells, 
ns; nasal septum, oe; oral epithelium.  
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2.3.2 Loss of BMP antagonism from axial domains results in rostral 
hypoplasia but not cleft palate 
Given that loss of BMP antagonism by Nog, specifically in the absence of Chordin 
(Chrd), can result in both micrognathia and holoprosencephaly (Anderson et al., 2002; 
Stottmann et al., 2001), we tested the role of axial Nog in craniofacial development by 
deleting Nog in the axial midline from early stages in the Chrd null background.  To do 
this, we combined a conditional null allele of Nog (Nogfx) (Stafford et al., 2011) with Shh-
GFP-Cre (Harfe et al., 2004), a recombination driver for the late node, notochord, and 
floor plate. Because these are all sites not only of Nog expression but also Chrd, as well 
as the fact that either Nog null or Chrd null alone shows extremely low penetrance and 
very mild craniofacial phenotypes, we made Shh-GFP-Cre;Noglacz/fx mutants with and 
without the presence of Chrd. Since we did not see any phenotypes in the mutant with 
the presence of Chrd (Shh-GFP-Cre;Noglacz/fx) (data not shown), we focused on the 
phenotypes of Shh-GFP-Cre; Noglacz/fx; Chrd-/- embryos. We observed that these mutants 
displayed a partially penetrant hypoplastic PA1 derivatives including the mandible and 
the maxilla (3/5), and some displayed holoprosencephaly as well (Fig. 2.2A-D). These 
data confirm what the models previously proposed - that is, underdeveloped PA1 
derivatives and/or holoprosencephaly in Chrd-/-;Nog-/+ mutants result from a lack of 
rostral axial BMP antagonism (Anderson et al., 2002; Stottmann et al., 2001). These data 
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collectively indicate that BMP antagonism in axial midline tissues promotes mandibular 
outgrowth, though none of these tissues contribute to the mandible.  
In contrast, none of the mutants showed two relevant defects of the Nog null. None 
exhibited a thickening of the mandible, implying some other deficit of Nog underlies the 
thickened mandible phenotype of the null (Stottmann et al., 2001; Wang et al., 2013). 
Moreover, the embryos lacking axial Nog did not display cleft palate. This indicates that 
the fully-penetrant cleft palate defect of Nog null mutants (He et al., 2010) does not result 
from a lack of axial BMP antagonism, but instead implies another tissue type must make 
Noggin protein for proper development of craniofacial structures, including 
palatogenesis. 
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Figure 2.2: BMP antagonism in axial domain is critical for development of PA1 
derivatives. 
 (A-D) Lateral view of wild-type (A, C) and Shh-GFPCre;Noglacz/fx;Chrd-/- (B, D) 
mutant whole-mount and skeletal-prep heads at P0 stage showing lack of Chrd and Nog 
in Shh-GFPCre domain results in hypomorphic PA1 derivatives compared with wild-
type littermate. Scale bars = 2 mm. (E, F) Example of holoprosencephaly in mutant 
embryo at E16.5 (F). (G, H) Mutant embryos without obvious phenotypes showing 
relatively normal development of palate indicated with an arrow and Meckel’s cartilage 
indicated with arrowheads (H). Scale bars = 1 mm.  
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2.3.3 Loss of Nog in neural crest cells results in an enlarged mandible 
Since many craniofacial skeletal elements are derived from NCCs, in which Nog 
is expressed (Stottmann et al., 2001), we assessed potential roles of Nog in NCCs using 
Wnt1-Cre, an NCC specific Cre driver (Danielian et al., 1998), in the development of 
craniofacial structures. In the head region, Wnt1-Cre is expressed in the dorsal neural 
folds from early stages of cranial NCC development, as well as in newly migrating 
NCCs (Jiang et al., 2000; Stottmann and Klingensmith, 2011). Given that Chrd is 
redundant with Nog in many developmental contexts (reviewed by (Klingensmith et al., 
2010), and that PCR data suggest Chrd is expressed at low levels in NCCs (M. Choi and 
JK, unpublished results), we tested the role of Nog in NCCs with and without wild-type 
allele(s) of Chrd. We found that the craniofacial phenotypes of Wnt1-Cre; Noglacz/fx animals 
were not noticeably different from Wnt1-Cre;Noglacz/fx;Chrd-/- (Fig. 2.4). Regardless of 
Chrd’s presence or absence, embryos lacking Nog from NCCs resulted in multiple 
craniofacial defects as described below. As a demonstration, the samples in Figure 2.3 
and 2.4 are from mutant animals of the genotype Wnt1-Cre; Noglacz/fx;Chrd-/-, whereas all 
other figures depict results from mutants that were Wnt1-Cre; Noglacz/fx.  
A striking phenotype in embryos lacking Nog in NCCs is an enlarged mandible 
(Fig. 2.3 & 2.7A, B) very similar to that of Nog null mice (Stottmann et al., 2001; Wang et 
al., 2013). Other craniofacial skeletal derivatives of NCCs, including laryngeal structures 
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such as hyoid and thyroid cartilages, were also hypermorphic in the mutant embryos 
(Fig. 2.5). Our results indicate that the thickened mandible phenotype of Nog mutants is 
due specifically to a lack of Noggin in NCCs, implying that attenuation of BMP 
signaling in the immediate environment of NCCs is necessary for proper mandibular 
morphogenesis. 




Figure 2.3: Absence of Nog in NCCs causes craniofacial defects. 
 (A, C) Anterior and posterior coronal sections through E15.5 wild-type 
embryonic head showing fusion of the palatal shelves and normal development of 
cartilages in the head. (B, D) Anterior and posterior coronal sections of Wnt1-Cre;Noglacz/fx 
;Chrd-/-mutant embryos showing cleft palate and enlarged cartilages at E15.5. ps; palatal 
shelves, t; tongue, mc; Meckel’s cartilage. Scale bars = 400 μm. 
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Figure 2.4: Lack of Nog in NCCs in the presence or absence of Chrd leads to an 
enlarged Meckel’s cartilage and cleft palate. 
 (A-B) Anterior coronal sections of E15.5 wild-type (A), Wnt1-Cre;Noglacz/fx (B), 
Wnt1-Cre;Noglacz/fx ;Chrd-/- (C) heads. Regardless of presence or absence of Chrd, lack of 
Nog in NCCs results in an enlarged nasal and Meckel’s cartilages and secondary cleft 
palate (B, C).  (D-F) Posterior coronal sections of E15.5 wild-type (D), Wnt1-Cre;Noglacz/fx 
(E), Wnt1-Cre;Noglacz/fx ;Chrd-/- (F) heads. Both types of mutants (E, F) show not fully 
elevated palatal shelves and a wide gap between the palatal shelves. mc; Meckel’s 
cartilage, nc; nasal cartilage, ps; palatal shelves. Scale bars = 1 mm. 





Figure 2.5: Laryngeal skeletal element in the Wnt1-Cre;Noglacz/fx mutant embryos is 
hypermorphic. 
 (A) E17.5 wild-type laryngeal skeleton show normal development in which 
hyoid and thyroid structures are separated. (B) An enlarged hyoid skeleton is joined 
with thyroid cartilage in mutant. The hyoid structure is over-ossified. Scale bars = 1mm. 
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2.3.4 Neural crest migration into PA1 occurs normally in embryos 
lacking Nog in NCCs 
We investigated the mechanisms underlying the enlarged mandibular skeletal 
element. A potentially relevant finding is that BMP signaling promotes delamination 
and collective migration of the NCCs (Burstyn-Cohen and Kalcheim, 2002; Hall and 
Erickson, 2003). In addition, in so far as Chrd-/-;Nog+/- embryos has increased neural crest 
production from the neural tube (Anderson et al., 2006), we hypothesized that ablating 
Nog from NCCs may increase production and migration of NCCs into the pharyngeal 
arches. However, we observed that the size of the PA1 in mutant embryos was not 
noticeably larger than that in wild type littermates at E10.5, when NCC migration is 
completed as Fig. 2.6 shows. We also assessed the expression of pharyngeal arch 
markers, including Dlx2, Dlx5, Msx1, and Barx1 (Fig. 2.6). Each marker was expressed 
similarly as in wild type embryos, suggesting normal patterning of the arch 
mesenchyme and ectoderm. These results suggest that altered NCC production and 
migration are not the primary cause of the enlarged mandibular skeleton observed in 
Wnt1-Cre;Noglacz/fx mutants. 
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Figure 2.6: PA1 shows normal expresion of patterning markers in the Wnt1-
Cre;Noglacz/fx mutant embryos. 
 (A-D, I-L) Normal expression of pharyngeal arch markers was shown in wild-
type embryos. (E-H, M-P) Expression of pharyngeal arch markers in Wnt1-Cre;Noglacz/fx 
mutant embryos. (A, B, E, F) Expression of Dlx5 mRNA in wild-type lateral and frontal 
views (A, B) and the similar expression pattern was observed in mutant lateral and 
frontal views (E, F). Expression of Msx1 (C, D, G, H), Dlx2 (I, J, M, N), and Barx1 (K, L, O, 
P) showed normal expression both in wild-type (C, D, I, J, K, L) and mutant (G, H, M, N, 
O, P) embryos. The size of PA1 is not different between wild-type (A-D, I-L) and mutant 
littermates (E-H, M-P). Scale bars = 500 μm. 
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2.3.5 Cell proliferation in Meckel’s cartilage and perichondrium is 
increased in the absence of Nog in NCCs  
To probe the cause of the enlarged mandible in mutants lacking Nog in NCCs, we 
performed cell proliferation assays in Meckel’s cartilage using a BrdU incorporation and 
detection to mark proliferating cells. Meckel’s cartilage first forms as a cartilage 
condensation around E11.5. At this stage, the size of the condensation between wild-
type and mutant does not show much difference (Fig. 2.7C, D). However, by E12.5, the 
mutant Meckel’s cartilage grows much faster and larger (Fig. 2.7E, F and Fig. 2.8 G, H). 
We found that cell proliferation both in the mesenchyme and in the perichondrium of 
mutant Meckel’s cartilage is increased at E12.5 and the diameter of the Meckel’s cartilage 
persistently grows larger in the mutant until E15.5 than in wild type (Fig. 2.7C-F, 2.9B, 
C).  
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Figure 2.7: Increased cell proliferation causes Meckel’s cartilage in Wnt1-
Cre;Noglacz/fx mice 
(A, B) Mandibular skeletal preparations. Wild-type mandible (A) shows normal 
development of Meckel’s cartilage (blue) and mandibular bone (purple) Double headed 
arrow shows antero- (a) posterior (p) direction of mandibular outgrowth. Enlarged 
Meckel’s cartilage in Wnt1-Cre;Noglacz/fx mutant (B) shows no obvious outgrowth defects. 
Scale bar = 1 mm. (C, D) Meckel’s cartilage in red dotted line. The size of wild-type (C) 
Meckel’s cartilage is similar to mutant (D) at E11.5. Scale bars = 100 μm. (E, F) Cell 
proliferation in the Meckel’s cartilage. Cell proliferation was increased in the mutant (F) 
Meckel’s cartilage at E12.5, compared with cell proliferation in wild-type (E) Meckel’s 
cartilage. Scale bars = 100 μm. 
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Previous studies indicate that Hh signaling regulates mandibular development. For 
example, lack of Hh signaling in NCCs resulted in a hypoplastic mandible (Jeong et al., 
2004; Jeong et al., 2003; Melnick et al., 2005), whereas activating Hh signaling in NCCs 
increased the size of facial primordial (Jeong et al., 2004). Accordingly, one hypothesis 
for the increased mandibular size and underlying cell proliferation is upregulation of Hh 
signaling when BMP receptor activation is increased in NCCs due to a loss of Nog from 
these cells. To investigate if activating BMP signaling induces ectopic Hh signaling in the 
developing mandible, we assessed the state of Hh signaling upon elevation of BMP 
signaling in NCCs. To do this, we drove expression of an activated BMP receptor 1A 
(caBMPr1a) transgene (Rodriguez et al., 2010) specifically in NCCs, and included a 
Ptch1-lacz transgene, an established, obligate reporter of Hh signaling (Goodrich et al., 
1997). At E13.5, Ptch1-lacz staining was apparent in the Meckel’s cartilage of these Wnt1-
Cre; caBMPr1a;Ptch1lacz mutants, while no blue cells were found in the wild-type Meckel’s 
cartilage (Fig. 2.8).  
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Figure 2.8: Hh signaling is upregulated in the Meckel’s cartilage of mice with 
upregulated BMP signaling. 
 (A, B) Meckel’s cartilage in red dotted line. Complementary experiment using 
constitutively active BMP receptor 1a (caBMPr1a) in combination with Wnt1-Cre showed 
overexpressing BMP signaling in NCCs caused ectopic expression of Hh signaling in 
mutant Meckel’s cartilage, as revealed by Ptch-lacz (B). Wild-type (A) Meckel’s cartilage 
showed no beta-galactosidase activity. Mutant (B) Meckel’s cartilage showed beta-
galactosidase activity (blue), indicating ectopic Hh signaling. Scale bar = 100 μm. 
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We also performed quantitative real time PCR (qPCR) to assess the level of Hh 
signaling and to determine if the increased Hh signaling activity might be reflected by 
increased expression of any Hh ligand. Our qPCR results showed increased expression of 
Hh transcriptional target genes (Fig. 2.9D). Moreover, we observed that Indian hedgehog (Ihh) 
expression is significantly increased in the mutant mandible. Together, these data 
suggest that in mandibular NCCs, increased BMP receptor activation leads to increased 
Ihh transcription, which then leads to increased Hh signaling, a known NCC mitogen. 
This in turn implies that the enlarged mandibular phenotype of embryos lacking Nog in 
NCCs may result from increased cell proliferation caused by elevated Hh signaling. 
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Figure 2.9: Meckel’s cartilage overgrowth and Hh signaling upregulation in 
mice lacking Nog from NCCs.  
(A) Mandibular outgrowth in the anteroposterior direction as shown in (Fig. 
3.7A) is not different between wild-type and mutant embryos. (B) The diameter of 
Meckel’s cartilage showed similar size at E11.5 between wild-type and mutant. 
However, after E12.5 mutant Meckel’s cartilage started rapidly growing and the growth 
persisted at E15.5, while growth rate in wild-type Meckel’s cartilage was diminished. (C) 
Increased cell proliferation in both perichondrium (peri) and mesenchyme (mes) in 
Meckel’s cartilage of Wnt1-Cre;Noglacz/fx mutant was statistically significant at E12.5. (D) 
qPCR results indicate upregulated Hh signaling in the mutant Meckel’s cartilage was 
due to upregulated Ihh expression. P<0.05. 
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2.3.6 Ablating Nog from NCCs results in secondary cleft palate 
Beyond an enlarged mandible, loss of Nog expression in NCCs results in other 
craniofacial skeletal defects. While many defective skeletal elements are enlarged in 
mutants, (eg the nasal cartilage), hypoplasia occurs in a few membranous bones, such as 
the palatal bone (Fig. 2.17) and those of the cranial vault (data not shown). Although 
primary palatal development appeared unaffected in embryos lacking Nog specifically 
in neural crest derivatives, Wnt1-Cre; Noglacz/fx embryos show overt secondary cleft palate 
(Fig. 2.10). Although the cause of cleft palate in Nog mutants was previously attributed 
to a lack of Nog expression in the oral epithelium (He et al., 2010), our results indicate 
that a key contributor to the cleft palate phenotype in Nog nulls is a lack of Nog in 
NCCs. 
To investigate the etiology of the palatal defects in Wnt1-Cre;Noglacz/fx mutant 
mice, we performed detailed morphological and histological analyses of palatal shelves 
at different stages of development. We first assessed the growth of the palatal shelves. 
At E13.5 palatal shelves of control and mutant embryos showed no clear differences in 
shape or size (Fig. 2.11A-F). We used BrdU incorporation assays to assess cell 
proliferation in the palatal shelf mesenchyme at this stage. We saw no significant 
difference between wild type and mutant embryos (Fig. 2.12). Thus both the gross size 
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and shape of the palatal shelves, as well as cell proliferation within the largely NCC-
derived mesenchyme, show no difference.  
We next tested whether patterning markers are correctly expressed in the mutant 
palatal shelves. During palatal development, specific genes are expressed along the 
anterior-posterior axis of the secondary palatal shelves. These markers are informative 
indicators to assess patterning defects in the mutant palatal shelves. Shox2 is normally 
expressed in the anterior palatal shelves (Yu et al., 2005). Shox2 null mice exhibit a rare 
form of cleft palate in which primary and secondary palatal shelves do not fuse properly 
(Yu et al., 2005). Shox2 expression is greatly reduced in the anterior palatal shelves of 
Nog null embryos at E13.5 (He et al., 2010). However, Shox2 expression was not altered 
in the palatal shelves of Wnt1-Cre;Noglacz/fx embryos (Fig. 2.13A, E).  
Besides being a patterning marker for the developing palate, Tbx22 is also a 
context-dependent downstream target gene of BMP signaling (Higashihori et al., 2010). 
Explant culture experiments using facial primordia and palatal shelves suggest that 
Tbx22 expression is regulated by BMP signaling (Fuchs et al., 2010). Its expression in the 
palatal shelves is found posteriorly. Loss of Tbx22 results in submucous cleft palate in 
mice and human (Braybrook et al., 2001). Tbx22 null mice show reduced palatal bone 
due to delay in the osteoblast maturation (Pauws et al., 2009). However, our results 
showed that Tbx22 expression is not altered in the Wnt1-Cre;Noglacz/fx mutant palatal 
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shelves at E13.5. qPCR analysis also indicates that expression level of Tbx22 is 
unchanged in the mutant palatal shelves (Fig. 2.14), although the size of the palatal bone 
is greatly reduced (Fig. 2.13B, F, 2.17C, D). This is consistent with normal proliferation 
seen in the mutant palatal shelves (Fig. 2.12). These results, as well as the lack of 
evidence for change in cell proliferation in the mutant palatal shelves suggest that 
altered Tbx22 expression in the Wnt1-Cre;Noglacz/fx palatal shelves is not the main cause of 
the smaller palatal bone and cleft palate in this mutant. Expression of two other palatal 
shelf markers, Barx1 and Efnb2, are also similarly expressed between wild-type and 
mutant embryos (Fig. 2.13C, D, G, and H).  
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Figure 2.10: Nog in NCCs is required for proper palatogenesis. 
(A, B) A wild-type E15.5 mouse showing normal palatal development in which 
the palatal shelves fuse by this stage (A) compared with the secondary cleft palate in 
Wnt1-Cre;Noglacz/fx (B). (C, D) A wild-type P0 mouse showing normal palatal 
development (C), overt cleft palate in Wnt1-Cre;Noglacz/fx at P0 is obvious by this stage (D). 
Scale bars = 1 mm.  
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2.3.7 Nog in NCCs is not required for palatal fusion 
One of the common causes of cleft palate is a defect in palatal fusion. For the 
bilateral palatal shelves to properly fuse, both sides need to come in close proximity for 
fusion, aided by secretion of extracellular matrix that helps bind the two sides (d'Amaro 
et al., 2012; Gato et al., 2002; Morris-Wiman and Brinkley, 1992). Upon contact of the 
opposing palatal shelves, dynamic tissue remodeling including apoptosis and changes 
in gene expression occur at the medial edge epithelium (MEE) (Huang et al., 2011; 
Nawshad et al., 2007; Xu et al., 2006). To test if Nog in NCCs is important for palatal 
fusion, we performed palatal shelf explant cultures. Palatal shelves were harvested from 
E13.5 embryos, and placed in contact with each other in culture medium such that their 
medial surfaces were juxtaposed. After 72 hours, both wild-type and mutant palatal 
shelves fused normally (Fig. 2.13I, J). These data indicate Nog in NCCs is not necessary 
for palatal fusion, in turn suggesting that failure of palatal shelf fusion is not the cause of 
the secondary cleft palate phenotype that occurs when Nog is absent from NCCs. 
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Figure 2.11: Palatal shelf development in Wnt1-Cre;Noglacz/fx is normal before 
elevation. 
 (A-F) Anterior to posterior level matched coronal sections of E13.5 control (A-C) 
and mutant (D-F) littermates. (G- L) Anterior to posterior level matched coronal sections 
of E14.5 control (G-I) and mutant (J-L) littermates. Sections shown in the left column (A, 
D) are anterior secondary palate. Sections shown in the left column (G, J) are from the 
elevated secondary palate region. Mutant palatal shelves (J) often show incomplete 
elevation of palatal shelves. Sections shown in the middle column (B, E, H, K) are from 
the middle of the secondary palate region. Sections shown in the right column (C, F, I, L) 
are from the posterior soft palate region. Scale bars = 400 μm. 
 






Figure 2.12: Cell proliferation in palatal shelves is not different from wild-type 
and mutant embryos. 
(A, B) numbers of BrdU-positive cells per unit area in the palatal shelves of E12.5 
(A) and E13.5 (B) were counted and compared between wild-type and Wnt1-Cre;Noglacz/fx 
mutant littermates. They showed no statistically significant difference in cell 
proliferation.    ns, nasal septum; ps, palatal shelf. 
A                                                                                B 
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Figure 2.13: Growth and fusion steps of palatal development are not disrupted 
in Wnt1-Cre;Noglacz/fx mutant mice. 
(A-E) Anterior and posterior local characteristics in the secondary palatal shelves 
are not altered in the Wnt1-Cre;Noglacz;fx mutant mice. (A, E) Shox2 mRNA expression was 
restricted to the anterior palatal shelves in E13.5 wild-type (A) and mutant (E) 
littermates. (B-D, F-H) Expression of Tbx22 (B, F), Barx1 (C, G), and Efnb2 (D, H) mRNA 
was restricted to the posterior region of the E13.5 palatal shelves in both wild-type (B-D) 
and mutant (F-H) embryos. (I, J) Arrowheads indicate the point where palatal shelf 
fusion has taken place. Palatal shelves in mutant (J) fuse normally as wild-type (I). Scale 
bars = 100 μm.  
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Figure 2.14: Expression of Tbx22 shows no difference between wild-type and 
mutant palatal shelves. 
Quantitative real time PCR shows a similar level of Tbx22 expression in the 
palatal shelves of wild-type and Wnt1-Cre;Noglacz/fx.  
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2.3.8 Failed palatal shelf elevation likely results from dismorphic skull 
base skeletal structure 
As noted above, the size of palatal shelves in mutant embryos prior to palatal 
shelf elevation showed no overt differences relative to wild-type palatal shelves at E13.5. 
However, we noticed that by E14.5 anterior palatal shelves in mutants were elevated 
horizontally above the tongue, yet were not close to each other; by contrast, control 
palatal shelves were fusing at this stage (Fig. 2.11G-L). We observed that the angle of the 
mutant palatal shelves gets wider progressively from anterior to posterior (Fig. 2.15E, F). 
Surprisingly, we found ectopic skeletal element invasion into the further posterior 
palatal shelves of mutant embryos at E13.5 at which palatal shelf elevation has not 
started (Fig. 2.15A, B). By E14.5 the skeletal element occupied majority of the posterior 
palatal shelves (Fig. 2.15C, D). Analysis of stained skeletal preparations revealed that the 
overgrown skeletal element in the posterior palatal shelves was the pterygoid bone (Fig. 
2.17). The pterygoid bone is derived from NCCs (McBratney-Owen et al., 2008). Further, 
the antero-posterior (AP) and medial-lateral (ML) lengths of skull base structure were 
compared, and we found that the AP length of mutant skull base was significantly 
shorter while the ML width of mutant skull base was longer than those of wild-type 
embryos (Fig. 2.17 & 2.18).  We also found that the presphenoid and the basisphenoid in 
mutant embryos prematurely fused (Fig. 2.17). These results suggest that the shorter 
skull base caused by prematurely fused presphenoid and basisphenoid displaces an 
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enlarged pterygoid bone anteriorly, which in turn allows the enlarged pterygoid bone to 
invade into the posterior palatal shelves, preventing proper elevation of the palatal 
shelves in the mutant lacking Nog in NCCs. Similar phenotypes were observed in Nog 
null embryos (Fig. 2.21).  
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Figure 2.15: Pterygoid bone invades the posterior palatal shelves in the Wnt1-
Cre;Noglacz/fx mutant palate. 
(A, B) Before palatal shelf elevation at E13.5, pterygoid is not obvious in wild-
type embryo (A), but it is already much larger in the Wnt1-Cre;Noglacz/fx mutant and it 
invades into the posterior part of palatal shelves (B). (C, D) Pterygoid bone appears in 
wild-type at E14.5 (C), while it is further growing in mutant palatal shelves (D). (E, F) 
Coronal sections of palatal bone region. Completely elevated and fused wild-type 
palatal shelves (E) and palatal shelves were elevated but the angle of elevation was 
wider in the Wnt1-Cre;Noglacz/fx mutant littermate (F). Scale bars = 100 μm for A, B, C, D, 
500 μm for E, F. 
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Figure 2.16: Posterior palatal shelf angle is wider in Wnt1-Cre;Noglacz/fx. 
The angle of palatal elevation was recorded and compared between wild-type 
and mutant littermates. 
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Figure 2.17: Skull base bones in mutant are dysmorphic. 
 (A, B) skeletal preparation showing posterior view of the skull base and palate. 
Compared with the width of wild-type skull (A), the width of mutant skull is wider (B). 
(C, D) Isolated skull base and the palatal bone region from the skeletal preps. The 
bilateral palatal bones are in contact in wild-type embryo at E17.5 (C). The palatal bones 
are smaller and far apart. Pterygoid bone is enlarged and dysmorphic in the skeletal 
prep of mutant littermate at E17.5 (D). pb, palatal bone; pt, pterygoid; prs, presphenoid; 
bs, basisphenoid; a, anterior; p, posterior; ml, medial-lateral.




Figure 2.18: The sizes of skull base width and length are statistically different 
between wild-type and mutant embryos. 
The length and width of the skull base were recorded and compared between 
wild-type and mutant skeletal preparations at E17.5. pb, palatal bone; pt, pterygoid. *P-
value < 0.05, **P-value < 0.01. 
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2.4 Discussion 
In this study, we used tissue specific gene knockout mouse models to probe the 
roles of two distinct domains of Nog in regulating craniofacial development. We found 
that the axial midline domain of BMP antagonism is critical for outgrowth of the 
mandibular bud of PA1, which swells with the immigration of NCC cells. Our data 
suggest an indirect effect of axial Nog in promoting the survival of these NCCs. Later, in 
NCCs and their derivatives, Nog activity regulates development of mandibular and 
maxillary craniofacial skeletal elements that are derived from NCCs. By upregulating 
BMP signaling in NCCs, we found that Meckel’s cartilage became strikingly enlarged as 
a result of greatly increased cell proliferation; this was accompanied by increased Hh 
signaling, a possible mitogenic cue for some NCC derivatives. We also found that 
mutants lacking Nog in NCC derivatives show secondary cleft palate, likely due to 
defects in bones of the skull base, particularly an enlarged pterygoid. Together, these 
results reveal distinct roles of Nog in axial domains for early PA1 development and in 
the NCC lineage for regulating later development of craniofacial skeletal elements. 
2.4.1 BMP antagonism by Nog and Chrd from the axial midline 
promotes mandibular outgrowth 
Our previous studies with Chrd-/-;Nog-/- and Chrd-/-;Nog+/- embryos revealed a 
requirement for these BMP antagonists in proper generation of the NCCs that populate 
PA1 (Anderson et al., 2006; Stottmann et al., 2001). Lowering the genetic dosage of Nog 
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in the absence of Chrd caused a somewhat increased emigration of NCCs from the dorsal 
neural folds, but instead of expanded mandibular buds, they were deficient; this was 
because a high level of NCC apoptosis in the pharyngeal region (Anderson et al., 2006). 
One possibility was that lack of expression of these BMP antagonists in NCCs causes 
their death and the resulting mandibular hypoplasia. This is not the case, because we 
saw no outgrowth defect when we ablated Nog specifically in NCCs, regardless of 
whether Chrd was present or not. Instead, we found that in the absence of Chrd, ablating 
Nog from the axial midline (notochord and floor plate) results in mandibular hypoplasia 
very similar to that observed in Chrd;Nog mutants. If Chrd were present, loss of Nog from 
the axial midline had no such effect. The axial midline domain of Nog is therefore the 
relevant source of expression. 
Our results imply that decreased BMP antagonism at the axial midline leads to a 
failure to attenuate BMP signaling in the pharyngeal environment as NCCs migrate 
through to populate the mandibular arch. One possibility is that increased BMP 
signaling in NCCs causes their apoptosis. If this were true, then expression of an 
activated BMP receptor in NCCs should cause their apoptosis. When we did this 
experiment, by expressing an activated BMP receptor (Rodriguez et al., 2010) in 
migratory NCCs, we saw the opposite phenotype - an enlarged mandible. Therefore, it 
is more likely that increased BMP activity caused by loss of axial BMP antagonism is 
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leading to lower levels of an NCC survival cue. Fgf8 has been shown to promote NCC 
survival during mandibular outgrowth. We previously found that pharyngeal Fgf8 
expression is reduced in Chrd;Nog mutants, and that beads soaked in BMP caused 
decreased expression of Fgf8 in mandibular arch explants, whereas beads soaked in 
carrier had no effect (Stottmann et al., 2001). Together with these earlier results, our data 
further support a mechanism in which reduced axial BMP antagonism leads to increased 
pharyngeal BMP activity, which in turn reduces expression of Fgf8 in the pharyngeal 
ectoderm and endoderm. This in turn results in less NCC survival as these cells colonize 
and populate the mandibular bud (Fig. 2.19 & 20). 
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Figure 2.19: Model of the roles of Nog in development of craniofacial 
development. 
Earlier expression of Nog in axial domains promotes NCC survival by inducing 
secondary signaling such as Fgf8 and Hh signaling. However, in later stages, Nog 
regulates skeletogenesis by balancing level of BMP signaling. In chondrocytes, Nog 
regulates size of cartilage by suppressing cell proliferation. When BMP attenuation is not 
enough, chondrocyte proliferation/ differentiation is promoted possibly through ectopic 
Ihh expression. 
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2.4.2 Nog expression in NCCs regulates Meckel’s cartilage and 
mandibular development 
As noted above, loss of Nog expression from the NCCs, via tissue-specific gene 
ablation with Wnt1-Cre, resulted in an enlarged mandible. The enlarged mandibular 
phenotype is very similar to that seen in Nog nulls (Fig. 2.21) (Stottmann et al., 2001; 
Wang et al., 2013), and was not noticeably different from Wnt1-Cre;Noglacz/fx;Chrd-/-. Thus 
in mandibular development per se, as opposed to mandibular bud outgrowth, there 
appears to be no redundancy of Nog with Chrd. Our results are consistent with a recent 
study which reported that BMP4 overexpression in NCCs at E10.5 also resulted in 
micrognathia (Bonilla-Claudio et al., 2012). Earlier in development, embryos lacking Nog 
in NCCs (Wnt1-Cre;Noglacz/fx mice) showed normal size pharyngeal arches, and several 
arch markers that are also BMP downstream target genes showed normal expression 
patterns at E10.5 (Fig. 2.6). These results further suggest that Nog activity in NCCs is not 
necessary for early stages of mandibular development, but rather is necessary for proper 
skeletogenesis within the developing mandibular prominence. 
We found that the enlarged mandible phenotype occurred not only when Nog 
was ablated from NCCs via Wnt1Cre, but also when the same recombination driver was 
used to express an activated BMP receptor in NCCs. This result suggests that the NCCs 
themselves, and their derivatives, need attenuation of BMP signal transduction to 
undergo proper development in the mandibular bud. These derivatives are likely to be 
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chondrocytes, as expression of an activated BMP receptor construct in these cells results 
in a similarly enlarged mandible as a result of expanded Meckel’s cartilage (Wang et al., 
2013). 
Our studies with Wnt1-Cre;Noglacz/fx mutants indicated greatly increased cell 
proliferation in the perichondrial area of Meckel’s cartilage relative to normal controls. A 
similar increase in cell proliferation was noted in embryos expressing an activated BMP 
receptor in chondrocytes (Wang et al., 2013). Consistent with studies suggesting the 
ability of BMP signaling upregulation in NCCs to cause increased cell proliferation in 
Meckel’s cartilage (Hu et al., 2008; Wang et al., 2013), the increased size of the mandible 
may be a direct effect of an increased level of chondrocyte proliferation triggered by less 
attenuation of BMP signaling by Nog. An alternative explanation is that the increased 
proliferation results form some other cue. We found that a known positive cytokine 
regulator of chondrocytic cell proliferation, Indian hedgehog (Ihh) (Minina et al., 2001), 
was expressed at increased levels when BMP signaling was upregulated in the NCC 
lineage. Accordingly, a second possibility is that in the context of the developing 
Meckel’s cartilage, BMP signaling in NCCs positively regulates Ihh activity, which in 
turn promotes chondrocyte proliferation. At least in endochondral ossification, BMP 
signaling is reported to positively regulate Ihh expression which, in turn, promotes cell 
proliferation (Minina et al., 2002). This may be true in Meckel’s cartilage as well. A 
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caveat to this model is that in the absence of Ihh, in mutants lacking the gene, the size of 
the mandible is not greatly diminished (St-Jacques et al., 1999). We would thus posit that 
Ihh can promote chondrocyte proliferation in Meckel’s cartilage, but is not essential for 
it. In any case, we suggest that a key function of Nog in chondrocytes derived from NCC 
cells is to limit proliferation by attenuating BMP activity (Fig. 2.20). 
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Figure 2.20: Summary of the roles of Nog in development of craniofacial 
development. 
Nog is expressed in two relevant domains for craniofacial development – NCCs 
and axial domains. When Nog is ablated in NCCs, an enlarged mandible and cleft palate 
result without mandibular outgrowth defects. When axial domain of BMP antagonism is 
absent, mandibular outgrowth defects and holoprosencephaly occur. Nog null mutant 
embryos exhibit phenotypes of two mutants combined, which are an enlarged mandible, 
cleft palate, mandibular outgrowth defects, and holoprosencephaly. 
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2.4.3 Noggin activity and the regulation of palatal development 
In addition to an enlarged mandible, Wnt1-cre;Noglacz/fx embryos exhibited almost 
fully penetrant secondary cleft palate. A previous study characterized the cleft palate of 
the Nog null (He et al., 2010), which also includes primary cleft palate. Nog is expressed 
in the oral epithelium, which showed increased cell death in Nog null mutants. He et al 
(2010) expressed activated BMP receptor in the epithelium, and found that the resulting 
embryos had cleft palate. These findings suggested that the cleft palate of Nog mice 
results from increased BMP signaling in the oral epithelium. By contrast, we have found 
that ablation of Nog exclusively in the NCC lineage, which contributes to the 
mesenchyme but not the epithelium of the forming palate, also causes severe secondary 
cleft palate. Together, these studies suggest that Nog plays multiple tissue-specific roles 
in palatal development (Fig. 2.19). 
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Figure 2.21: Nog null embryos exhibit an enlarged pterygoid. 
 (A, B) Skeletal prep showing skull base skeletal element at P0. Wild-type 
embryos show normal development of palate and pterygoid bone (A), while small 
palatal bone and an enlarged pterygoid bone in Nog null embryos (B). (C) Pterygoid 
bone invades in the posterior palatal shelves in Nog null at E13.5. Scale bars = 1 mm.  
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In embryos lacking Noggin activity in NCC derivatives, the mutant palatal bones 
were hypomorphic, which in principle could directly cause submucous cleft palate. 
However, the primary cause of overt cleft palate in Wnt1-cre;Noglacz/fx embryos is most 
likely due to a defect in posterior palatal elevation. The palatal shelf elevation was likely 
inhibited by the presence of an enlarged pterygoid bone that is located posterior to the 
palatal shelves. Pterygoid cartilage is derived from NCCs and develops through 
endochondral ossification (McBratney-Owen et al., 2008). We found that in culture the 
mutant palatal shelves could fuse seemingly as well as in wildtype, but in the context of 
the rest of the mutant viscerocranium they likely never get close enough. These data 
suggest that a dysmorphic skull base component can greatly influence palatogenesis. 
We further observed that in mutants lacking Nog in NCC derivatives, the mutant 
mouse skull base was shorter and wider than in wild type embryos. Studies concerning 
human patients show great correlations between morphological anomalies in the skull 
base and the incidence of cleft palate. For example, in 3-month-old children with 
complete cleft, there was an increased width of the cranial base, and an increased width 
of the spheno-occipital synchondrosis - the cartilaginous junction between the 
basisphenoid and basioccipital bones - in newborns, compared with patients with 
incomplete cleft (Molsted et al., 1993; Molsted et al., 1995). Although a correlation 
between complete clefts and skull base anomalies was found, it is difficult to establish 
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etiology from these results. However, our mouse model suggests a novel mechanism of 
cleft palate. The skeletal elements of the skull base are structurally complex and 
intricately interconnected. We suggest that an abnormally formed bone outside those 
directly involved in palatal development can influence overall structural development of 
the skull base and indirectly cause cleft palate. It is likely that morphological anomalies 
in the skull base that affect palatal development are overlooked as part of the etiology of 
cleft palate. 
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3. Roles of Noggin in Neural Tube Closure 
The following chapter is now being prepared in preparation for submission. 
Adhesion assay in this study was the collaborative effort of Rebecca Thomason, Manuel 
Lopez (McClay lab) and Andy Ravanelli (Klingensmith lab).  
 
3.1 Introduction 
Neural tube defects (NTDs) are common human birth defects, occurring 6% of all 
births worldwide (Wallingford et al., 2013). NTDs result from one or more failures 
during neurulation. Causes of NTDs include genetic and environmental factors 
including maternal alcohol consumption and smoking (Grewal et al., 2008). Among 
human NTDs, spina bifida (unfused spine) and exencephaly (open brain) are the most 
prevalent defects. Numerous mouse models of NTDs have been identified so far. 
However, genetic, cellular and molecular mechanisms of proper neural tube 
development and the causes of NTDs are still poorly understood.  
The neural tube that consists of pseudostratified neuroepithelium is the 
precursor to the central nervous system. Proper neural tube closure is a prerequisite for 
the following organogenesis. Previously, we showed that Nog null mice exhibit fully 
penetrant spina bifida and to a much lesser extent exencephaly (Stottmann et al., 2006). 
When Nog or Chrd is absent, expression of several BMP transcriptional target genes is 
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upregulated in the dorsal neural folds (Anderson et al., 2006).  Furthermore, the 
incidence of exencephaly in Nog null embryos greatly depends on genetic background. 
For example, Nog-/- in a 129/Sv background exhibits 100% exencephaly while Nog-/- in a 
mixed background of 129:C57BL show 65% penetrance of exencephaly (Stottmann et al., 
2006).  
In our model of neural tube closure, there are mechanistic differences between 
caudal (spinal) neural tube closure where spina bifida occurs and cranial neural tube 
closure where exencephaly occurs. In the cranial neural tube closure, dorsolateral hinge 
points (DLHPs), as well as median hinge point (MHP) formation, are necessary for both 
edges of elevated lateral neural plate meet to fuse to each other. For instance, in Nog null 
mutants, exencephaly results due to the defective of DLHP formation (Stottmann et al., 
2006). Studies show that when a Shh-soaked bead was placed near a neural fold, DLHP 
formation was inhibited (Ybot-Gonzalez et al., 2002). In addition, Hh signaling is 
ectopically expressed in the roof plate of neural tube of exencephalic Nog null mutant 
embryos without inducing Shh ligand expression while no Hh signaling upregulation 
was observed in the non-exencephalic Nog null embryos (Stottmann et al., 2006). It has 
also been shown that Shh acts as a negative regulator of Nog during neurulation. Nog 
expression in the neural fold was abolished when Shh soaked beads were implanted. 
Further, dorsal Nog expression was extended ventrally in Shh null embryos (Ybot-
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Gonzalez et al., 2007). These data suggest that Nog and Hh signaling interact and the 
precise regulation of these genes is essential for proper formation of DLHP and by 
extension neural tube formation. However, whether just activating Hh signaling in the 
roof plate of the neural tube is sufficient to cause exencephaly in Nog-/- mutant mice 
remains as yet unexamined.  
In contrast, our model of caudal neural tube closure suggests that proper 
paraxial mesoderm formation is essential to maintain closing caudal neural tube. In 
addition to this model, there is another potential mechanism for spinal NTD in Nog null 
mice. Spina bifida in Nog null mice occurs at full penetrance regardless the background. 
Surprisingly, when embryos were dissected between E8 and E9, mutant neural tube at 
the spinal region was closed. However, after E11, the neural folds spread apart, resulting 
in spina bifida (Stottmann et al., 2006). These results suggest that neural folds normally 
elevate and come into contact, but the closing neural folds do not remain closed in Nog 
null embryos. Our hypothesis here is that Nog mutant embryos are not capable of 
maintaining the closing neural tube due to insufficient adhesion between neural folds. 
This hypothesis is consistent with several recent findings that BMP signaling regulates 
expression of cadherins (Eom et al., 2013; Eom et al., 2011, 2012; Shoval et al., 2007). 
Interestingly, Grainy head-like (Grhl) family of developmental transcription factors, 
Grhl2 regulates expression of the adherens junction gene E-cadherin and the tight 
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junction gene claudin 4 (Cldn4) in different types of epithelia (Werth et al., 2010). Grhl2 
and Grhl3 have region specific and cooperative roles in neural tube closure; Grhl2 
mutant mice show exencephaly, Grhl3 mutants result in spina bifida, and Grhl2+/-;Grhl3-/- 
compound mutant embryos exhibit more severe phenotypes than either mutant alone 
(Rifat et al., 2010). One study indicates that BMP-signaling dependent Grhl1 expression 
is required for epidermal differentiation in Xenopus laevis (Tao et al., 2005). However, the 
association, if any, between BMP signaling pathway and Grhl2/Grhl3 genes in 
neurulation remains unknown. 
Here, we used conditional gene ablation to generate tissue-specific Nog mutants 
to identify the domain(s) important for neural tube closure because Nog is expressed 
multiple domains which are potentially relevant for proper neural tube formation. We 
also assessed adhesiveness in the Nog heterozygous neuroepithelium, and examined the 
expression of Grhls in Nog null mutant embryos. Finally, we investigated if ectopic 
upregulation of Hh signaling in Nog null embryos causes exencephaly. We used Cre-
mediated activation of a constitutively active form of Smo (caSmo) to ectopically 
upregulate Hh signaling in the roof plate of the neural tube (Wnt1-Cre;c-Smo) to see if the 
mutant mice recapitulate NTDs in Nog null mice. 
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3.2 Materials and Methods 
3.2.1 Mice 
The mutant mice used in the detection of domains important for NTDs are the 
same crosses (Wnt1-Cre;Noglacz/fx, ShhGFP-Cre;Noglacz/fx;Chrd-/-, and Wnt1-Cre;caBMPr1a) 
used in the previous chapter. 
For activation of Hh signaling in the roof plate, conditional activation of Smo 
floxed mice (caSmo) was used in combination with Wnt1-Cre mice. All these mice were 
maintained on a random outbred ICR genetic background.  
3.2.2 Gene expression assays 
For whole mount in situ hybridization, embryos were dissected from pregnant 
mice, fixed overnight in 4% PFA at 4°C. The fixed embryos were dehydrated through 
25%, 50%, 75%, and 100% ethanol, and stored in 100% ethanol at -20°. Whole mount in 
situ hybridization was carried out using previously described protocol (Belo et al., 1997) 
with hybridization temperature of 65°C. Primers for making Grhl2 and Grhl3 probes 
were designed using Primer3 (Koressaar and Remm, 2007). Standard techniques were 
used for β-galactosidase staining (Hogan, 1994).  
3.2.3 Adhesion assay 
This experimental technique was established and performed by Rebecca 
Thomason, Manuel Lopez (McClay lab) and Andy Ravanelli (Klingensmith lab).  
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384 well plates with flat polystyrene/coverglass bottom (Nunc #142761) were 
prepared in advance. Each test was run in triplicate.  For cell-substrate adhesion 
experiments, fibronectin was deposited on the well bottoms with the concentrations 
determined empirically as the concentration required for reference standards to achieve 
maximum initial binding at 4°C (Lotz et al., 1989). Three types of cell lines were 
prepared for cell-cell adhesion experiments. Stably transfected N-CAM expressing CHO 
lines were obtained from Urs Rutishauser (Johnson et al., 2005). Cells that were 
harvested from culture were washed and diluted into serum-free DME medium.  They 
were deposited to the bottoms of the wells of the 384-well plates by centrifugation at 50 
xg rcf.  It was confirmed that the substrate was largely covered by the unlabeled 
monolayers of cells, each containing ~ 50,000 cells. Similarly, an E-cadherin-expressing 
cell line (MDAMB-435 E435-E-cad cell line) (Meigs et al., 2002), or an A431D cell line 
transfected with N-cadherin (Lewis et al., 1997) was also deposited as a monolayer for 
measuring adhesion to E-cadherin or measuring adhesion to N-cadherin respectively.  
Reference cells or neural tube cells that were stained either with RITC or cell 
tracker green as above were counted and diluted to approximately the same number 
with a desired final concentration of 5000 cells/ml and mixed. The cells were dispensed 
so that each test well of the 384 well Nunc plate received about 250-500 cells of each 
color.  Finally, DME medium was poured into each well to form a slightly positive 
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meniscus at the top of the well after addition of the cells.  Each well of the plate was 
sealed carefully with transparent packing tap. All of these steps were performed on ice 
to keep the cells and cultures at or below 4°C.  The plates were centrifuged gently for 3 
min so that all cells come into contact with the substrates (30x g, 3 min., 4°C).  And then, 
the plates were inverted and spun at a speed predetermined to remove about 50% of the 
reference cell population (5 min., 4°C, force given for each experiment below).  The 
plates were still kept inverted for analysis, cell counts, and imaging at 5X using 
Metamorph imaging software (Universal imaging). Each data point resulted from the 
average of at least three independent experiments that contained at least triplicate 
samples.  
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3.3 Results 
3.3.1 Deletion of Nog using ShhGFP-Cre exhibits short tail phenotype, 
but does not show NTDs.  
Nog null mice show fully penetrant spina bifida regardless of the background of 
the mice (Stottmann et al., 2006; Ybot-Gonzalez et al., 2007). Nog is expressed in the 
multiple domains that are potentially relevant to neural tube development (Fig. 2.1A, B, 
3. 1A, B). In our model of Nog NTDs, spina bifida is caused by insufficient development 
of somite due to the lack of Nog from axial domains (Stottmann et al., 2006). To test this 
hypotheses, ShhGFP-Cre, axial domain specific Cre was used. ShhGFP-Cre is expressed in 
the axial midline including the floor plate of the neural tube and the notochord during 
neurulation. Although mutant embryos showed the characteristic Nog null phenotype of 
a short tail, neither obvious defects in somite development nor NTDs was present (Fig. 
3.2A, B). The mutant embryos occasionally exhibited holoprosencephaly, and 
micrognathia as described in the previous chapter, but no cleft palate was found in the 
mutants (Fig. 2.2G, H). Additionally, they exhibited fused toes between the fourth and 
the fifth toes. The fused toe phenotype is not observed in Nog null embryos. This could 
be due to the high sensitivity of the genetic interaction between Nog and Shh in the toes 
(Fig. 3.2C-F). Taken together, these results indicate that axial domains of Nog are not 
critical for either caudal or rostral neural tube closure. 
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Figure ‎3.1: Nog expression during neurulation. 
Nog is expressed in the roof plate of the closing neural folds (A). Nog is also 
expressed in the axial midline (B). More detailed Nog expression in axial midline is 
found in the Fig. 2.1B.   
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Figure ‎3.2: Short tail and fused toe phenotypes in ShhGFP-Cre;Noglacz/fx;Chrd-/- 
embryos. 
(A, B) Normal tail development in wild-type littermate (A). Ablating axial 
midline of BMP antagonists results in short tail. Because of the underdeveloped sacral 
structure, small amount of blood is accumulated (B). (C, D) within the bracket, 4th and 5th 
toes are fused in ShhGFP-Cre;Noglacz/fx;Chrd-/- embryos (D) compared with normal 
development in wild-type embryo (C). (E, F) E17.5 skeletal prep showing normal toe 
development (E) and fused 4th and 5th toes in mutant embryos (F).  
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3.3.2 Nog heterozygous neural epithelium shows lower adhesion 
ability.  
Our previous data showed that Nog null mutant embryos have a closed spinal 
neural tube at earlier stage around E9.5. However, after E11.5 it appeared reopened. 
However, Nog heterozygous embryos do not show visible NTDs. Therefore, we 
hypothesized that Nog heterozygous neuroepithelial cells have decreased adhesive 
ability than those in wild-type embryos, which in turn, cannot maintain the closing 
neural tube intact when both alleles of Nog are lost. To test if Nog is associated with 
adhesiveness in the developing neuroepithelium, we dissociated neuroepithelial cells 
from the neural plate and the neural tube of Nog heterozygous and wild-type control 
embryos between E8.5 and E9.5.  
The technique employed for the adhesion assay is explained in detail in the 
Materials and Methods section of this chapter. Briefly, the adhesion assays include two 
parts - cell-cell and cell-substrate adhesion experiments. For cell-cell adhesion 
experiments, three different cell lines, stable neural crest adhesion molecule (N-CAM) 
expressing Chinese hamster ovary (CHO) cell lines (Johnson et al., 2005), E-cadherin-
expressing cell line (Meigs et al., 2002), and an N-cadherin-expressing A431D cell line 
(Lewis et al., 1997) were employed. The cells were deposited into the 384-well plates so 
that they formed a monolayer of cells. For cell-substrate adhesion experiments, 
fibronectin was added on the bottoms of the plates with the concentration necessary to 
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achieve maximum initial binding at 4 °C (Lotz et al., 1989). Neuroepithelium harvested 
from embryos was stained either with rhodamine isothiocyanate (RITC) or cell tracker 
green and added on to the plates that contained either E-cadherin-, N-cadherin-, or N-
CAM-expressing cells for cell-cell adhesion experiments, or fibronectin for cell-substrate 
adhesion experiments. The plates were spun gently for 3 minutes and the cells that 
remained attached to the substrate or the monolayers of the cells after centrifugation 
were counted. The results show Nog heterozygous cells exhibited less cell adhesiveness 
(Fig. 2.3).  We found the largest difference in N-cadherin plate among all the adhesion 
molecules we tested. This is consistent with several other studies showing that 
expression of N-cadherin mRNA is upregulated by blocking BMP signaling while it is 
downregulated when BMP signaling is increased (Eom et al., 2011, 2012; Shoval et al., 
2007).  
As noted above, in these experiments, we used Nog heterozygous cells. Had we 
used cells from Nog null embryos, the effect would have been greater. Adhesiveness in 
the closing neural folds in Nog null embryos would be less than the hypothetical 
threshold of failure, leading to reopening the neural tube. The changes in adhesiveness 
could affect morphogenesis of neural tube development, which may in turn cause 
defects in maintaining the neural tube closure.  
  




Figure ‎3.3: Nog heterozygous cells display an adhesive deficit relative to WT 
cells.  
In multiple experiments wt cells showed better adhesiveness to fibronectin, N-
CAM, N-Cadherin and E-Cadherin than Noggin +/-  heterozygotic cells. Error bars 
include data from all experiments.  The large error for fibronectin is due to the subtle 
differences in the stage of embryos.  The adhesiveness to fibronectin changes 
dynamically in a short period of time. As neural tube folding proceeds, adhesion to 
fibronectin decreases in wild-type cells such that the difference between wild-type cells 
and Noggin +/- cells diminishes. 
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3.3.3 Expression of Grhl2 and Grhl3 is altered in the Nog null mutant 
embryos. 
In our adhesion molecule experiment, Nog heterozygous neuroepithelium 
showed less adhesion levels. BMP signaling regulates expression of several adhesion 
molecules including Cadherins. Grhl2 and Grhl3 null mice exhibit region specific NTDs 
including exencephaly and spina bifida (Rifat et al., 2010), which are similar to Nog null 
NTDs. However, an in situ experiment shows that expression of Nog or BMP2 was not 
altered in Grhl3 null embryos (Rifat et al., 2010). These results indicate that BMP 
signaling is not the downstream target of Grhl3 at least. It is still possible that Grhl genes 
are downstream targets of BMP signaling pathway. To investigate this possibility, we 
performed whole mount in situ hybridization against Grhl2 and Grhl3 in Nog null 
embryos. Grhl2 was normally expressed in the front and midbrain region in the wild-
type embryos. However, its expression was lost in the Nog null embryos at E9.5 (Fig 
3.4A, B). Similarly, Grhl3 expression was diminished especially in the lower spinal 
region where spina bifida occurs in the Nog null embryos at E10.5 (Fig 3.4C, D). These 
results suggest that potential regulation of Grhl genes by Nog in neurulation.  
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Figure ‎3.4: Grhl genes may be downregulated in the Nog null embryos.  
(A, B) Grhl2 expression is detected frontal part of the head in wild-type embryo 
(A), Grhl2 expression is almost absent in the same area of mutant head (B). (C, D) Grhl3 
mRNAs were detected less in Nog null embryo (D). N=3, each. 
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3.3.4 Ablating Nog in the roof plate does not cause NTDs, but 
upregulating BMP signaling in the roof plate results in partially 
penetrant exencephaly.  
Nog is expressed in another potentially relevant domain, the roof plate of the 
neural tube, for proper neural tube development. To examine if Nog in the roof plate of 
the neural tube is critical for proper neural tube development, we performed tissue 
specific Nog ablation using Wnt1-Cre. Mutant embryos lacking Nog from the Wnt1-Cre 
domain resulted in multiple craniofacial defects including fully penetrant cleft palate 
and an enlarged mandible shown in previous chapter (Fig. 2.3 & 2.4). However, there 
were no obvious defects, including NTDs, in the earlier stages. On the other hand, when 
BMP signaling is upregulated in the same domain using Wnt1-Cre and constitutively 
active BMP receptor 1a (caBMPr1a), approximately, half of the embryos exhibited 
exencephaly in addition to severe craniofacial defects including fully penetrant cleft 
palate and, to the lesser extent, cleft lip (Fig. 3.5). There was no consistent pattern 
between the severity of craniofacial defects and exencephaly. These results suggest that 
upregulating BMP signaling in the roof plate of the neural tube causes exencephaly, but 
ablating Nog from the roof plate does not upregulate BMP signaling high enough to 
cause exencephaly. Alternatively, Nog expression in the roof plate is not critical for 
proper neural tube development.  
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Figure ‎3.5: Activating BMP receptor 1a in the roof plate results in partially 
penetrant exencephaly.  
 (A, B) Wnt1-Cre;caBMPr1a embryos showing no exencephaly (A), however, 
about half of the mutant mice exhibit exencephaly with other craniofacial defects shown 
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3.3.5 Upregulating Hh signaling in the roof plate results in incomplete 
penetrance of exencephaly. 
Previously, it was reported that Nog null embryos exhibited exencephaly. The 
phenotype was background dependent (Stottmann et al., 2006). However, one important 
finding is that exencephalic Nog null embryos always display ectopic Hh signaling in the 
roof plate of the neural tube although non-exencephalic Nog null embryos do not show 
ectopic Hh signaling upregulation (Stottmann et al., 2006).  It is known that Hh signaling 
inhibits DLHP formation (Ybot-Gonzalez et al., 2007). Given the previous observations, 
we hypothesized that exencephaly in Nog null embryos is due to upregulating Hh 
signaling in the roof plate.  
To test this hypothesis, we genetically upregulated Hh signaling in the Wnt1-Cre 
domain and compared the resulting phenotypes to those observed in Nog null embryos. 
We used Noglacz  mice in undefined background in this study. Wnt1-Cre is expressed in 
the roof plate and NCCs. To upregulate Hh signaling, we used cre-inducible allele of 
constitutively active Smo (caSmo) in combination with Wnt1-Cre. We confirmed that 
Wnt1-Cre;caSmo embryos successfully upregulated Hh signaling in the roof plate of the 
neural tube by whole-mount in situ hybridization detecting expression of the Shh 
receptor and transcriptional target, Ptch (Fig. 3.7A, B) without upregulating Shh (Fig. 
3.6).  
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Figure ‎3.6: Shh is not upregulated in Wnt1-Cre;caSmo embryo.  
Similar Shh expression pattern is detected in wild-type (A) and Wnt1-Cre;caSmo 
embryos (B) by whole mount in situ hybridization. (N=3, each) 
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Although penetrance of exencephaly was higher in Wnt1cre;caSmo (67%, N=9) at 
E9.5 than Nog null embryos (20%, N=6), it was not fully penetrant. Moreover, when 
dissected in later stage, the number of exencephalic embryos in Wnt1cre;caSmo was 
dramatically decreased (10%, N=10) (Fig. 3.9). In the later stages (E13.5~), only 10% of 
the Wnt1-Cre;caSmo embryos exhibited the open brain phenotype although the mutant 
embryos without exencephaly still showed an abnormally swollen head (Fig 3.9). Next, 
we measured angles of DLHPs and compared between Wnt1cre;caSmo and Nog null 
mutants (Table. 3.1). Angles of DLHPs in Nog null mutants are not different from those 
of Wnt1cre;caSmo (Fig. 3.8). Altogether these results suggest that upregulation of Hh 
signaling alone is not enough to cause exencephaly in Nog null embryos. It is also 
possible that variation of intensity in Hh signaling upregulation results in different 
phenotypic outcomes.  
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Table ‎3.1: Open NT phenotype in Nog-/- and Wnt1-Cre;caSmo mutants 
 14-25 somites 25 somite < 
WT N=13, 0% N/A 
Nog-/- N=10, 20% N/A 
Wnt1-Cre;caSmo N=9, 67% N=10, 10% 
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Figure ‎3.7: Ectopic Hh signaling is confirmed non-exencephalic Wnt1-
Cre:caSmo mutant.  
(A, B) Normal Ptch expression is found in the floor plate of the neural tube in 
wild-type embryo (A). Ectopic Ptch expression was seen in Wnt1-Cre;caSmo embryo to 
confirm upregulation of Hh signaling in non-exencephalic neural tube (B). (C, D) As 
previously shown, Nog null without exencephaly shows no Hh upregulation in the roof 
plate (C), while exencephalic Nog null shows ectopic Ptch expression in the roof plate 
(D). (N=3, each) 
 
  135 
 
 
Figure ‎3.8: Angles of DLHP in Nog null and Wnt-Cre;caSmo were compared. 
Angles of DLHP between wild-type (blue dots) and Nog null (pink dots) or 
between wild-type and Wnt1-Cre;caSmo (purple dots) are significantly different. 
However, difference is not observed angles between Nog null and Wnt1-Cre;caSmo 
embryos when one outlier in Nog null was discarded from the data point. 
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Figure ‎3.9: Upregulating Hh signaling in the roof plate cause partially 
penetrant exencephaly.  
(A) Wild-type embryo showing normal neural tube development. N=20/20 (B, C) 
Upregulating Hh signaling in the roof plate results in partially penetrant exencephaly, 
N=1/10 (B), while some show no exencephaly, N=9/10 (C).  
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3.4 Discussion 
In this study, we used tissue specific gene knockout mouse models to probe the 
roles of two distinct domains of Nog in regulating neural tube closure. When axial 
midline of BMP antagonists, Nog and Chrd, are absent, a short-tail like phenotype is 
present. However, no obvious NTDs were found in this class of mutant embryos. The 
other domain of Nog we tested was the roof plate of the neural tube using Wnt1-Cre. 
When Nog was ablated in the closing neural folds, which become roof plate of the neural 
tube, neural tube closure happens without any problem.  
Since our previous study revealed that exencephalic Nog null mice exhibit 
ectopic Hh signaling upregulation in the roof plate of the neural tube, we hypothesized 
that upregulating Hh signaling in the roof plate can recapitulate exencephaly phenotype 
in Nog null mice. When constitutively active Smo was expressed in the roof plate, the 
resulting phenotype was partially penetrant exencephaly.  
In our in vitro adhesion assay using neuroepithelium, Nog heterozygous cells 
showed decreased adhesion ability compared with wild-type cells. To further 
investigate molecular mechanisms underlying NTDs in Nog null mice, expression of 
Grhl2 and Grhl3, which cause NTDs when one of them is absent, were examined.  We 
found gene expression of both genes to be diminished in Nog null embryos. Together, 
our data and others suggest that Nog in other domain(s) than axial midline or roof plate, 
  138 
such as somite-domain of Nog, or multiple domains of Nog are responsible for proper 
neural tube closure. Nog may regulate expression of adhesion molecules that are critical 
for neurulation, possibly through Grhl family genes. 
3.4.1 Roof plate domain or axial midline domain of Nog alone does 
not cause NTDs.  
Previous studies show that Nog null embryos exhibit fully penetrant spina bifida 
and to the lesser extent exencephaly. To investigate which domain of Nog is important 
for neural tube development, we used tissue specific gene ablation technique to 
knockout Nog from the roof plate of the neural tube. Although Nog is expressed in the 
roof plate of the closing neural tube, lack of Nog in the roof plate caused no NTDs. This 
result suggests Nog domain important for neural tube closure is not the roof plate. 
Alternatively, Wnt1-Cre expression may be too late to ablate Nog expression important 
for neural tube closure. Nog is also expressed in the axial midline including the 
notochord and the floor plate of the neural tube. One study suggests that axial domain 
of Nog is important for neural tube and somite development (McMahon et al., 1998). 
ShhGFP-Cre was used to ablate Nog from the axial midline. Although lack of Nog from 
axial midline in Chrd null background (ShhGFP-Cre;Noglacz/fx;Chrd-/-) exhibited skeletal 
defects such as fused toes and micrognathia as well as small blood accumulation in the 
sacral area due to the caudal regression, no obvious NTDs were observed. One of the 
reasons that ShhGFP-Cre;Noglacz/fx;Chrd-/-did not show NTDs may be due to insufficient 
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Hh signaling upregulation in the mutant mice. ShhGFP-Cre was made by gene-targeting 
method to insert a gene that encodes gfpcre fusion protein into Shh locus (Harfe et al., 
2004). Shh is a factor known to inhibit formation of DLHP that is critical for rostral 
neural tube folding (Ybot-Gonzalez et al., 2007). Exencephalic Nog null embryos always 
showed ectopic Hh signaling upregulation in the roof plate (Stottmann et al., 2006). Hh 
signaling upregulation by ablating Nog may be compensated by introduction of ShhGFP-
Cre.  
In the previous studies and our model of lumbar neural tube closure, axial 
domain of Nog is important for somite development, which in turn affects neural tube 
closure (McMahon et al., 1998; Stottmann et al., 2006; Wijgerde et al., 2005). However, 
ablating Nog from axial midline resulted in normal somite development. This result 
indicates that axial domain of Nog is not critical for somite development. Yet, whether 
proper somite development is required for subsequent neural tube closure remains 
unknown. Clearly Nog is necessary for somitogenesis. Nog regulates expression of 
somite patterning genes (Wijgerde et al., 2005). Importantly, Nog is expressed in the 
dorsal lip of the dermomyotome where Pax3-expressing cells first induce expression of 
MyoD and Myf5 to develop myotomal cells (Reshef et al., 1998). The roles of this domain 
of Nog for neural tube development should be tested in the future study.  
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We found that Nog in the roof plate or axial domain alone does not cause NTDs 
or defects in somitogenesis. Nog expression in the somite itself may be directly 
responsible for somite development and indirectly for neural tube development. 
Alternatively, multiple domains, such as axial midline and somite domains, may act 
cooperatively in neurulation and somitogenesis. Further assessments are required for 
identifying Nog domain(s) important for proper neural tube development. 
3.4.2 Nog’s regulation of adhesion molecules in neural tube 
development.  
Nog null mutant neural tube shows partially closed neural tube in the caudal 
spine before E10.5 and by E14.5 spina bifida becomes apparent by reopening of the 
neural tube (Stottmann et al., 2006). We hypothesized that Nog null mice do not have 
sufficient cell-cell and/or cell-substrate adhesion molecules that are essential for proper 
neural tube closure.  To test this hypothesis, we performed adhesion assays that were 
described in detail in the Materials and Methods section of this chapter. The adhesion 
assay was originally established to measure hypothetical threshold of morphogenetic 
processes in the neural tube closure. It has been shown that natural genetic variations 
make one strain of mice more susceptible to a certain defect to occur over another strain 
of mice (Fleming and Copp, 2000). That is, using adhesion assay, we may be able to find 
“morphogenetic threshold of adhesiveness” beyond which it affects neural tube 
development.  
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We found that neuroepitheial cells from Nog heterozygous embryos, which do 
not exhibit NTDs, have less adhesiveness to fibronectin, N-CAM, N-cadherin, and E-
cadherin, with significantly high adhesiveness to N-cadherin. These results suggest that 
Nog heterozygous embryos have, in total, adhesive ability above the threshold although 
they showed less adhesiveness to multiple adhesion molecules because Nog 
heterozygous embryos do not exhibit NTDs. Zebrafish Nodal signaling mutants display 
NTDs in the presumptive forebrain region. N-cadherin expression and localization to 
the membrane in the mutants are reduced (Aquilina-Beck et al., 2007). The adhesion 
assay experiments show that Nog heterozygous neuroepithelium exhibits reduced 
adhesiveness to N-cadherin although we still do not know how this adhesiveness affects 
neurulation in Nog embryos. It is likely that Nog homozygous neuroepithelium will 
show further reduction of adhesiveness. In addition to adhesion assay using Nog null 
neuroepithelium, it is also important to examine if localization and expression level of 
the adhesion molecules are altered in the closing neural folds of Nog null embryos.  
We found that adhesiveness to cadherins was reduced in Nog heterozygous 
neuroepithelium. Yet, the genetic network regulating cadherins in the context of neural 
tube closure remains unknown. Interestingly, lack of grainyhead-like (Grhl) family genes 
results in region specific NTDs that are similar to the ones seen in Nog null mice. Grhl2 
mutant mice exhibit exencephaly with failed DLHP formation (Rifat et al., 2010), while 
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Grhl3 null mice show spina bifida due to defects in fusion of the neural folds (Copp et 
al., 2003; Rifat et al., 2010). One recent study in Xenopus demonstrates that Grhl1 gene is 
regulated by BMP4 signaling cascade in development of epidermis (Tao et al., 2005). We 
hypothesized that BMP signaling negatively regulates expression of Grhl genes in the 
neural tube closure. To investigate if expression of Grhl genes is altered in Nog null 
embryos, whole-mount in situ hybridization was performed. The results suggest that the 
expression of both genes was greatly, but not completely, reduced in Nog null mutant 
ectoderm. Together, our data may indicate that BMP signaling regulation of cadherins in 
the neural tube closure is at least partially through Grhl genes. Further molecular 
analyses are awaited. 
3.4.3 Hh signaling upregulation in the roof plate is necessary but not 
sufficient to cause exencephaly in Nog null. 
Previously, our lab showed that Nog null embryos exhibit partially penetrant 
exencephaly, and the exencephalic embryos show Hh upregulation in the roof plate of 
the neural tube (Stottmann et al., 2006). Shh is a known inhibitor for DLHP formation 
(Ybot-Gonzalez et al., 2002). To examine if upregulating Hh signaling is the cause of 
exencephaly, we used constitutively active form of Smo mice (caSmo) in combination 
with Wnt1-Cre mice. Although we confirmed that Hh signaling was upregulated in the 
roof plate of Wnt1-Cre;caSmo mice by detecting a Shh receptor and transcriptional target 
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Ptch mRNA (Fig. 3.7), only 67% of embryos between 14 and 25 somite stages exhibited 
exencephaly (Table 3.1).  
Hh signaling gradient from the ventral neural tube plays an essential role in the 
dorsoventral patterning of the neural tube in collaboration with BMP signaling gradient 
from the dorsal side of the neural tube. Precise regulation of gradient is the key step for 
proper patterning of the neural tube and subsequent generation of different types of 
neurons. Roles of Hh-signaling related genes in the neural tube development have been 
extensively studied. Loss of Shh causes craniofacial malformations and defects in 
development of the brain, but neural tube closure occurs normally (Chiang et al., 1996). 
NTDs’ phenotypes in loss of function mutations of other Hh signaling components were 
described in various literatures. Smo mutants have defects in heart development and die 
around E9.5, but neural tube closure occurs normally (Zhang et al., 2001). Loss of other 
Hh signaling components such as Dipatched1 or over-expression of Ptch reduces Hh 
signaling activity, preventing normal patterning in the neural tube, and yet, no defects 
in neural tube closure are observed (Goodrich et al., 1999; Kawakami et al., 2002).  
On the other hand, activating Hh signaling often causes NTDs. Loss of Ptch, 
which causes Hh signaling activation, results in open neural tube (Goodrich et al., 1997). 
Loss of Sufu, another negative regulator of Hh signaling, results in defects in neural tube 
closure (Cooper et al., 2005). Both mutants show disrupted dorsoventral patterning in 
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the neural tube (Cooper et al., 2005; Goodrich et al., 1997). Notably, some studies 
indicate correlations between neural tube closure defects and degree of disruption in 
dorsoventral patterning in the neural tube of the mutant mice with Hh signaling 
upregulation (Ikeda et al., 2001; Murdoch and Copp, 2010; Norman et al., 2009; Patterson 
et al., 2009). Loss of a negative Hh signaling regulator, Tubby-like protein 3 (Tulp3) 
causes NTDs. Significantly, Tulp3 null embryos have higher degree of dorsoventral 
patterning defects with higher penetrance of NTDs than Tulp3 hypomorphs (Ikeda et al., 
2001; Norman et al., 2009; Patterson et al., 2009).  
Taken together, our results suggest that upregulating Hh signaling in the roof 
plate is a prerequisite for the exencephalic phenotype in Nog null embryos, but there 
may be critical threshold after which it affects neural tube development and causes fully 
penetrant exencephaly. Our studies did not extend to examine the degree of defects in 
dorsoventral patterning of Wnt1-Cre;caSmo and exencephalic Nog mutants. However, 
domains as well as intensity of Hh signaling activation will affect patterning of the 
neural tube. It is likely that wider area of Hh activation that causes severe dorsoventral 
patterning defects in the neural tube is required for increase the penetrance of 
exencephaly. Nog null mice in a 129/Sv background show fully penetrant exencephaly 
(Stottmann et al., 2006). Genetic variations may have distinct expressivity level of other 
BMP antagonists. This in turn could cause different level of Hh upregulation in Nog null 
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mice. Future studies that examine more precise interaction and regulation between BMP 
signaling and Hh signaling in neurulation will help us better understand about proper 
neural tube development.  
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4. Summary and future directions 
BMP signaling has been implicated in numerous processes of embryonic 
development. Precise regulation of BMP signaling activity level is controlled by BMP 
antagonists. Our studies describe multiple roles of one such antagonist molecule, Noggin 
(Nog), in development of craniofacial skeleton and neural tube. The primary themes of 
this dissertation are (1) the elucidation of roles of distinct domains of Nog; axial midline 
and NCCs, in craniofacial skeletogenesis, (2) the identification of mechanisms of NTDs 
in Nog null mutant. These themes improve our understanding of normal development 
and etiology of defects in craniofacial skeleton and neural tube closure. This chapter 
summarizes our findings and discusses some implications for future research.  
 
4.1 Nog in axial midline and pharyngeal arch 1 development.  
Our original studies concerning mandibular outgrowth defects in BMP 
antagonist Nog and Chrd compound mutants (Nog+/-;Chrd-/-) demonstrate that proper 
development of the derivatives of pharyngeal arch 1 (PA1) requires these antagonists 
(Stottmann et al., 2001). Although knockout of either gene, Nog or Chrd, only causes mild 
mandibular phenotypes, Nog+/-;Chrd-/- embryos exhibit a whole spectrum of mandibular 
truncation phenotypes ranging from almost normal to agnathia (no jaw) (Stottmann et 
al., 2001). In addition, explant culture experiments using PA1 suggest that upregulating 
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BMP signaling suppresses FGF8 expression in ectoderm of PA1 and increases cell death 
in NCCs. FGF8 is a NCC survival and patterning factor in populating NCCs in PA1 
(Trumpp et al., 1999). However, during the development of craniofacial skeletal 
elements, Nog is expressed in multiple relevant domains including axial midline such as 
the notochord, the floor plate of the neural tube, and the foregut endoderm of the 
laryngeal region, and NCCs from which most of the craniofacial skeleton are derived. 
Therefore, it is important to identify which domain(s) of Nog are required for proper 
mandibular development. To address this, we first conducted a conditional genetic 
ablation experiment using Nogfx  (Stafford et al., 2011) allele in combination with axial-
midline-specific ShhGFP-Cre (Harfe et al., 2004) carrying NoglacZ on a Chrd null 
background. We focused on the phenotypes of ShhGFP-Cre;Noglacz/fx;Chrd-/- embryos.  
Ablation of Nog from the axial midline domain by ShhGFP-Cre on a Chrd null 
background resulted in high penetrance of micrognathia (3/5). The embryos that caused 
mandibular outgrowth defects were also accompanied with truncated maxilla. 
Additionally, some embryos exhibited holoprosencephaly – i.e., fused forebrain due to 
midline truncation. At earlier stage around E11.5, ShhGFP-Cre;Noglacz/fx;Chrd-/- embryos 
showed smaller PA1 than wild-type littermates. The smaller PA1 is often observed in 
other mutants with mandibular outgrowth defects. These studies allowed us to identify 
an important role of Nog in axial midline domain for development of PA1 derivatives, 
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indicating that Nog’s indirect role for proper craniofacial development because none of 
these tissues contribute to the craniofacial skeletal elements. Significantly, parietal bone 
which is a mesoderm derivative, also became smaller ShhGFP-Cre;Noglacz/fx;Chrd-/-with 
mandibular outgrowth defects. In contrast to this indirect effect of Nog in axial midline 
to PA1 derivatives, this domain of Nog may also have direct effect on development of 
mesoderm derived craniofacial skeleton.  Notably, other Nog craniofacial phenotypes, 
such as thickened mandibular bone (Stottmann et al., 2006) and cleft palate (He et al., 
2010) were not present in ShhGFP-Cre;Noglacz/fx;Chrd-/-.  
Our studies relied largely on analyses of histology and skeletal preparation. It is 
important to examine if the mandibular outgrowth defects seen in ShhGFP-
Cre;Noglacz/fx;Chrd-/- embryos result from increased cell death in PA1 as previous studies of 
Nog null embryos suggested by immnohistochemistry (Stottmann et al., 2001). Indirect 
effect of Nog in axial midline domain likely alters secondary signaling that influences 
PA1 development. Shh and FGF8 synergistically drive development of craniofacial 
cartilage by promoting NCC survival (Trumpp et al., 1999; Tucker et al., 1999). It would 
be more informative to identify which secondary signaling(s) are induced or suppressed 
by loss of Nog in axial domains, and upregulating BMP signaling in the mutant.  
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4.2 Nog in NCCs and craniofacial skeletogenesis.   
Ablating Nog from axial midline caused hypoplastic PA1 derivatives including 
micrognathia and a shorter maxilla. These phenotypes resulted from loss of Nog’s 
indirect role in craniofacial development. However, previous studies indicate other roles 
of Nog in craniofacial development. Nog null embryos showed thickened mandibular 
skeletal structure (Stottmann et al., 2001). Lack of Nog also exhibited fully penetrant 
primary and secondary cleft palate (He et al., 2010). These phenotypes were not present 
in ShhGFP-Cre;Noglacz/fx;Chrd-/-. However, craniofacial skeletal elements are mostly 
derived from NCCs. Nog is also expressed in NCCs. Therefore, it is essential to 
investigate Nog’s direct effect in the development of craniofacial skeleton. To assess this, 
we conducted another conditional genetic ablation experiment. This time, we used 
Wnt1-Cre, NCC-specific recombination driver, together with Nogfx allele to ablate Nog in 
NCCs. 
At the beginning of the genetic experiments, this genetic cross was done on a 
Chrd null background. Wnt1-Cre;Noglacz/fx;Chrd-/- embryos showed fully penetrant 
enlarged mandibular skeletal structure and secondary cleft palate. However, we found 
even when Chrd was present, Wnt1-Cre;Noglacz/fx embryos exhibited the same phenotypes 
as Wnt1-Cre;Noglacz/fx;Chrd-/- embryos. Consequently, we decided to examine Wnt1-
Cre;Noglacz/fx embryos.  
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In addition to enlarged mandibular skeletal structure, other cartilages - such as 
nasal cartilage - were also hypermorphic in Wnt1-Cre;Noglacz/fx embryos. Earlier studies 
show BMP2 mutant mice lack detectable migratory cranial NCCs (Kanzler et al., 2000). 
In chick experiment, migration of transplanted melanoma cells was inhibited by Nog 
(Busch et al., 2007). Since BMP signaling is required in the multiple steps in the NCC 
development - starting from the generation and migration to proliferation and 
differentiation of NCCs, and Wnt1-Cre;Noglacz/fx embryos showed enlarged NCC-derived 
craniofacial skeletal elements such as mandible and nasal cartilage, we hypothesized 
that increased NCC migration ventrally from the dorsal neural folds resulted in 
hypermorphic skeletal structures. However, embryos lacking Nog from NCCs showed 
normal size PA1 around E10.5 at which NCC migration should have completed. At this 
point, the size of the mutant head was not different from the wild-type head. Thus, NCC 
production and migration in Wnt1-Cre;Noglacz/fx embryos were largely unaffected. We 
also tested several PA1 patterning makers, such as Dlx5, Barx1, Msx1, and Dlx2. No 
patterning markers were altered in Wnt1-Cre;Noglacz/fx embryos. Notably, loss of Nog in 
NCCs did not exhibit micrognathia found in Nog null and ShhGFP-Cre;Noglacz/fx;Chrd-/-. 
These data indicate that critical roles of Nog in NCCs for development of craniofacial 
skeleton occur after NCC migration.  
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Contrary to our hypothesis, Nog expression in NCCs was not necessary for NCC 
production and migration. There are several potential reasons for this. One reason is that 
other BMP antagonists such as Gremlin and Twisted gastrulation that are expressed 
during NCC formation and migration could compensate for the loss of Nog in NCCs 
(Hsu et al., 1998; Scott et al., 2001; Stafford et al., 2011). A second reason could be that 
Nog may not be the primary BMP antagonist at this stage. It would be useful to see 
whether expression of other BMP antagonists is increased during NCC production and 
migration in the embryos lacking Nog in NCCs.  
 
4.3 Nog in NCCs and mandibular development. 
A previous study showed that Nog+/-;Chrd-/- compound mutant mice displayed a 
whole spectrum of mandibular outgrowth defects (Stottmann et al., 2001). Our studies 
concerning roles of Nog in axial midline domain revealed that this domain of Nog is 
critical for mandibular outgrowth. In addition to the indirect role of Nog in axial domain, 
we also found that ablation of Nog from NCCs does not cause mandibular outgrowth 
defects. Instead, lack of Nog in NCCs resulted in a thicker mandibular structure 
formation. It is important to investigate what mechanism causes hypermorphic 
mandibular skeletal structure.  
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During mandibular development, Meckel’s cartilage and mandibular bone are 
mostly derived from NCCs of PA1. Mandibular bone forms around Meckel’s cartilage 
using Meckel’s cartilage as a template. In mice, Meckel’s cartilage first appears at E11.5 
as a chondrocyte condensation, at E12.5 it starts forming rod-like shape, by E13.5 
Meckel’s cartilage becomes a single “V” shaped structure (Ramaesh and Bard, 2003) In 
our studies, we found the size of cartilage condensation was relatively similar between 
wild-type and Wnt1-Cre;Noglacz/fx embryos. However, by E13.5 the diameter of the 
Meckel’s cartilage became much larger in Wnt1-Cre;Noglacz/fx embryos. We used BrdU to 
investigate if this was due to increased cell proliferation. We found that Meckel’s 
cartilage in Wnt1-Cre;Noglacz/fx embryos showed increase cell proliferation at E12.5. 
Activating BMP signaling in NCCs only by Wnt1-Cre;R26RcaBmpr1a/+ similarly exhibited 
thickened Meckel’s cartilage as Wnt1-cre;Noglacz/fx . This result was consistent with a 
recent finding in which BMP receptor 1a was activated in the chondrocyte, and resulting 
phenotype was enlarged Meckel’s cartilage due to increased cell proliferation (Hu et al., 
2008; Wang et al., 2013).  
While we identified that enlarged mandible in Wnt1-Cre;Noglacz/fx embryos was 
due to increased cell proliferation in Meckel’s cartilage, the mechanism causing 
increased cell proliferation was not clear. Previous studies show an association between 
BMP signaling and Hh signaling in skeletal development. BMP signaling promotes Ihh 
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expression which, in turn, positively regulates cell proliferation in chondrocytes (Minina 
et al., 2002). We hypothesized that upregulating BMP signaling in Meckel’s cartilage 
induces Hh signaling upregulation. To assess this, Ptch-lacz, obligate reporter of Hh 
signaling, was incorporated in Wnt1-Cre;R26RcaBmpr1a/+. We found that Hh signaling was 
upregulated in Meckel’s cartilage of Wnt1-Cre;R26RcaBmpr1a/+ embryos. Moreover, qPCR 
data suggested that Hh upregulation in Meckel’s cartilage of Wnt1-Cre;R26RcaBmpr1a/+ was 
due to increased Ihh expression. These data may indicate that previous findings that 
BMP signaling induces Ihh signaling that promote chondrocyte proliferation in 
endochondral ossification also apply to mandibular development in which the structure 
is derived through non-endochondral ossification. However, it is important to examine 
whether increased Hh signaling in Meckel’s cartilage promote cell proliferation in mice 
lacking Nog from NCCs. Hh signaling can be artificially blocked by adding cyclopamine. 
Mandibular explant culture Wnt1-Cre;Noglacz/fx embryos with cyclopamine treatment 
followed by a BrdU incorporation experiment should reveal the answer to this question.  
 
4.4 Roles of Nog in palatal development.  
Nog null embryos previously showed primary and secondary cleft palate due to 
disrupted integrity of palatal epithelium (He et al., 2010). Cell proliferation was 
increased in the oral side of the palatal epithelium where ectopic pSmad activity was 
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observed in Nog null embryos, and palatal elevation was prevented by abnormal fusion 
between the posterior palate and the mandible (He et al., 2010). Activating BMP receptor 
1a in epithelium using K14-Cre also recapitulated abnormal fusion of palatal shelves to 
mandible seen in Nog null embryos (He et al., 2010). These data indicate an important 
role of Nog expression in epithelium for palatal development. However, we found that 
lack of Nog from NCCs also resulted in secondary cleft palate. It was important to 
investigate mechanisms of the cleft palate phenotype in Wnt1-Cre;Noglacz/fx embryos. 
During palatal development in mice, at E13 palatal shelves grow vertically and at 
E14 both sides of palatal shelves rotate and elevate to meet at the midline. By E15 both 
sides of palatal shelves fuse and form a complete palate. To identify which step of 
palatal development was disrupted in Wnt1-Cre;Noglacz/fx embryos, coronal sections of the 
head were carefully analyzed. We found normal growth of the mutant palatal shelves at 
E13.5 and the cell proliferation rate in the palatal shelves was not different between 
wild-type and Wnt1-Cre;Noglacz/fx embryos. In addition, palatal patterning genes - such as 
Shox2, Tbx22, Barx1, and Efnb2 - were also detected similarly in the palatal shelves of 
wild-type and Wnt1-Cre;Noglacz/fx embryos. Furthermore, explant culture of the palatal 
shelves showed palatal shelves of Wnt1-Cre;Noglacz/fx embryos retained the ability of 
palatal shelf fusion as wild-type palatal shelves. From these experiments, we did not 
find any defective steps during palatogenesis of mice lacking Nog from NCCs. However, 
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we noticed ectopic bone growth in the further posterior palatal shelves at E13.5 of Wnt1-
Cre;Noglacz/fx embryos. This bone was strikingly large, and it invaded in the growing 
posterior palatal shelves so that elevation of the palatal shelves seemed prevented. 
Conducting skeletal preparation, this invading bone was identified as an enlarged 
pterygoid bone. Hypomorphic palatal bone, which is often considered as a cause of 
submucous cleft palate, was also found in Wnt1-Cre;Noglacz/fx embryos. The cause of cleft 
palate in the mutant is likely due to disrupted elevation of the palatal shelves by ectopic 
pterygoid formation in the posterior palatal shelves. These results strongly suggest a 
novel mechanism of cleft palate, in which dysmorphic skull base component indirectly 
affects palatal development. Other craniofacial component may also influence 
palatogenesis. One study of patients with craniosynostosis, premature suture fusion of 
skull vault, found relatively wider cleft of soft palate in the patients (Iida et al., 1995). 
Understanding the distinct mechanisms underlying different types of cleft palate may 
help us find proper diagnosis, treatments, and prevention for cleft palate. Future 
research to understand the mechanisms is highly recommended, therefore. 
 
4.5 Nog in DLHP formation. 
It has been shown that formation of DLHPs is critical for cranial neural tube 
closure as exencephaly results if they do not form properly (Stottmann et al., 2006; 
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Werth et al., 2010; Ybot-Gonzalez et al., 2002). Our previous study also showed 
exencephaly in Nog null embryos resulted from disrupted DLHP formation (Stottmann 
et al., 2006). However, complete mechanisms of how the bending is formed are still 
uncertain. One recent study concerning chick neural tube development revealed that 
MHP, another important hinge point in the neural tube closure requires a two- 
dimensional canonical BMP activity gradient that creates a low and pulsed BMP activity 
in the MHP (Eom et al., 2011). This study also proposed a model that the MHP is formed 
through apical constriction caused by endocytosis of apical proteins, Par3 and N-
cadherin, which associate with phosphorylated Smad5/8 in a BMP-dependent manner 
(Eom et al., 2011). The similar mechanisms may be also applicable to DLHP formation. 
Identifying mechanisms of DLHP formation is also a critical theme, since defective 
DLHP formation is often seen in exencephalic mice with different gene mutations.  
DLHP formation may be also affected by the development of non-neural surface 
ectoderm. The surface ectoderm may have active role for neural tube closure, since 
removing the tissue surgically inhibits DLHP formation (Moury and Schoenwolf, 1995).  
Supporting evidence comes from studies of Grhl mutant mice (Pyrgaki et al., 2011; Rifat 
et al., 2010; Werth et al., 2010). Loss of Grhl2 or Grhl3 results in NTDs. Grhl genes are 
essential for development of non-neural epithelial cells. Interestingly, our in situ data 
indicate expression levels of Grhl genes in Nog null embryos may be reduced. Since Grhl 
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genes are expressed in the surface ectoderm, but not in the neural epithelium, it is 
unlikely that BMP signaling in Nog null directly regulates transcription of Grhl genes in 
the adjacent tissues. More detailed molecular analyses should reveal mechanisms of 
gene regulation and molecular control in DLHP formation.   
 
4.6 Nog and Hh signaling in neural tube closure. 
One of the original goals of our neural tube closure study was to determine if 
upregulating Hh signaling in the roof plate of the neural tube recapitulate exencephaly 
observed in Nog null embryos. Penetrance of exencephaly in Nog null embryos is greatly 
influenced by the genetic background, and exencephalic Nog null embryos always 
exhibited ectopic Hh upregulation (Stottmann et al., 2006). Shh is known to inhibit 
formation of DLHPs that are required for proper neural tube closure in the midbrain 
region (Ybot-Gonzalez et al., 2002). We hypothesized that upregulating Hh signaling in 
the roof plate results in exencephaly. To examine this, we conducted a genetic 
experiment that is activating Smo (caSmo) in the roof plate using Wnt1-Cre. We found 
that Wnt1-Cre;caSmo embryos cause partially penetrant (67%) exencephaly between 14 
and 25 somite stages.  
Ventral Hh is clearly important for neural tube development together with dorsal 
BMP signaling. These two signaling pathways synergistically and antagonistically act 
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together to form a correct neural tube. Importantly, ablating Hh signaling components 
affects neural tube patterning, but it does not cause NTDs (Goodrich et al., 1999; 
Kawakami et al., 2002). In contrast, activating Hh signaling components frequently 
causes defects in neural tube closure. Importantly, the degree of penetrance may depend 
on the level of ectopic Hh signaling upregulation. Tulp3 is a negative Hh signaling 
regulator. Tulp3 null embryos exhibited highly penetrant exencephaly (77%) while Tulp3 
hypomorphs resulted in much lower penetrance of exencephaly (37%) at E12.5 (Ikeda et 
al., 2001; Patterson et al., 2009). The degree of Hh signaling activation may affect severity 
of defects in the neural tube patterning, which in turn cause NTDs. 
Our findings of NTDs in Wnt1-Cre;caSmo embryos with previous studies suggest 
that Hh upregulation is a required factor, but just upregulating Hh signaling in the roof 
plate may not be sufficient to cause exencephaly in Nog null mice. Alternatively, the 
degree and domains of Hh signaling upregulation are also likely to influence the degree 
of perturbation in neural tube development. Since we used Wnt1-Cre to activate Hh 
signaling, ectopic Hh signaling was limited in the domain in which Wnt1-Cre was 
expressed. In Nog mutants with exencephaly may have Hh signaling upregulation in 
wider region that we may have missed. Future studies could examine dorsoventral 
patterning of the neural tube between exencephalic and non-exencephalic Nog mutant 
embryos to address this concern. 
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4.7 Nog and adhesion molecules in neural tube closure.  
Neural tube closure involves dynamic tissue morphogenesis. Both edges of a flat 
sheet of neural plate roll up, and juxtaposed neural folds fuse together across the dorsal 
midline, resulting in complete neural tube closure. Failure of any step during 
neurulation may result in NTDs. It is critical that the cells in the neural plate to produce 
the correct cytoskeletal and adhesion apparatus for this active tissue movement to occur. 
In our previous study, we showed that Nog null mice exhibited NTDs including 
exencephaly and spina bifida. Despite severe NTDs seen in Nog null mice, Nog 
heterozygous embryos had no obvious NTDs. We hypothesized that neuroepithelial 
cells in Nog heterozygous mice retain adhesive ability above the threshold but lower 
than ones in wild-type neuroepithelium so that no NTDs result. Therefore, one of 
important goals was to establish an adhesion assay that would quantitatively evaluate 
adhesion of cells during neural tube closure (details of the experimental methods are 
found in the previous chapter). Using this adhesion assay, we found neuroepithelium in 
Nog heterozygous embryos exhibits less adhesiveness against several adhesion 
molecules including N-CAM and E-cad. Significantly, neuroepitheial cells in wild-type 
embryos showed 40% more adherent to N-cadherin than ones in Nog heterozygous 
embryos. These data suggest that Nog heterozygous neuroepitheial cells greatly reduce 
adhesiveness that in turn may be important for proper neural tube morphogenesis. One 
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study showed that removal of N-cadherin causes exencephaly with increased cell death 
(Luo et al., 2006). Extensions to this study should be aimed at determining if these 
adhesion molecules are regulated in the transcription level, translation level, or even 
localization level. These studies would serve as another step to more fully integrate BMP 
antagonism’s contribution to neural tube development.   
 
4.8 Conclusion 
In this study, we focused on two most common and detrimental birth defects, 
craniofacial and neural tube defects and their development. Craniofacial skeletal 
structure is complex but elegant in that many distinct small bones and cartilages with 
different shapes come together and work cooperatively to function properly. The neural 
tube is a precursor to the brain and the spine. Correct development of these two organs 
is extremely important for ensuring quality of life as well as social acceptance. And yet, 
the processes of both craniofacial and neural tube development are unfortunately 
susceptible to genetic and environmental disruptions. Therefore, it is easy to understand 
that why studies of craniofacial and neural tube development have attracted so many 
researchers over a long period of time.  
Here, multiple roles of Noggin, a BMP antagonist in development of the neural 
tube and craniofacial skeletal elements are studied. During midbrain neural tube 
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closure, Nog’s BMP antagonism is likely to prevent ectopic expression of Hh signaling 
which inhibits DLHP formation. Regulation of adhesion molecules by Nog may be also a 
crucial step for proper neural tube development. Nog in axial domain is critical for 
proper development of PA1 since loss of Nog in axial domain resulted in hypoplastic 
PA1 derivatives including micrognathia. This suggests that axial midline domain of Nog 
is a key BMP antagonism for early craniofacial development. On the other hand, loss of 
Nog from NCCs caused hyperplastic Meckel’s cartilage formation due to increased cell 
proliferation in chondrocytes. In addition, Nog in NCCs plays an important role in 
regulating size and shape of skeletal elements of the skull base, which in turn could 
indirectly influence palatogenesis. Although this study revealed many answers in 
relation to the roles of Nog in development of craniofacial skeleton and neural tube 
closure, new interesting questions were also discovered. It is desirable that this 
dissertation will contribute to future researches, prevention, and treatments associated 
with developmental mechanisms and problems.  
  163 
References   
Anderson, R.M., Lawrence, A.R., Stottmann, R.W., Bachiller, D., Klingensmith, J., 2002. 
Chordin and noggin promote organizing centers of forebrain development in the mouse. 
Development 129, 4975-4987. 
 
Anderson, R.M., Stottmann, R.W., Choi, M., Klingensmith, J., 2006. Endogenous bone 
morphogenetic protein antagonists regulate mammalian neural crest generation and 
survival. Developmental dynamics : an official publication of the American Association 
of Anatomists 235, 2507-2520. 
 
Aquilina-Beck, A., Ilagan, K., Liu, Q., Liang, J.O., 2007. Nodal signaling is required for 
closure of the anterior neural tube in zebrafish. BMC developmental biology 7, 126. 
 
Bachiller, D., Klingensmith, J., Kemp, C., Belo, J.A., Anderson, R.M., May, S.R., 
McMahon, J.A., McMahon, A.P., Harland, R.M., Rossant, J., De Robertis, E.M., 2000. The 
organizer factors Chordin and Noggin are required for mouse forebrain development. 
Nature 403, 658-661. 
 
Baek, J.A., Lan, Y., Liu, H., Maltby, K.M., Mishina, Y., Jiang, R.L., 2011. Bmpr1a signaling 
plays critical roles in palatal shelf growth and palatal bone formation. Developmental 
Biology 350, 520-531. 
 
Bastir, M., Rosas, A., Stringer, C., Cuetara, J.M., Kruszynski, R., Weber, G.W., Ross, C.F., 
Ravosa, M.J., 2010. Effects of brain and facial size on basicranial form in human and 
primate evolution. Journal of Human Evolution 58, 424-431. 
 
Belo, J.A., Bouwmeester, T., Leyns, L., Kertesz, N., Gallo, M., Follettie, M., De Robertis, 
E.M., 1997. Cerberus-like is a secreted factor with neutralizing activity expressed in the 
anterior primitive endoderm of the mouse gastrula. Mech Dev 68, 45-57. 
 
Bonilla-Claudio, M., Wang, J., Bai, Y., Klysik, E., Selever, J., Martin, J.F., 2012. Bmp 
signaling regulates a dose-dependent transcriptional program to control facial skeletal 
development. Development 139, 709-719. 
 
Braybrook, C., Doudney, K., Marcano, A.C., Arnason, A., Bjornsson, A., Patton, M.A., 
Goodfellow, P.J., Moore, G.E., Stanier, P., 2001. The T-box transcription factor gene 
TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet 29, 179-183. 
  164 
Brewer, S., Feng, W., Huang, J., Sullivan, S., Williams, T., 2004. Wnt1-Cre-mediated 
deletion of AP-2alpha causes multiple neural crest-related defects. Dev Biol 267, 135-152. 
 
Brunet, C.L., Sharpe, P.M., Ferguson, M.W., 1995. Inhibition of TGF-beta 3 (but not TGF-
beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion. Int J Dev 
Biol 39, 345-355. 
 
Brunet, L.J., McMahon, J.A., McMahon, A.P., Harland, R.M., 1998. Noggin, cartilage 
morphogenesis, and joint formation in the mammalian skeleton. Science 280, 1455-1457. 
 
Burstyn-Cohen, T., Kalcheim, C., 2002. Association between the cell cycle and neural 
crest delamination through specific regulation of G1/S transition. Dev Cell 3, 383-395. 
 
Busch, C., Drews, U., Garbe, C., Eisele, S.R., Oppitz, M., 2007. Neural crest cell migration 
of mouse B16-F1 melanoma cells transplanted into the chick embryo is inhibited by the 
BMP-antagonist noggin. International journal of oncology 31, 1367-1378. 
 
Chai, Y., Jiang, X., Ito, Y., Bringas, P., Jr., Han, J., Rowitch, D.H., Soriano, P., McMahon, 
A.P., Sucov, H.M., 2000a. Fate of the mammalian cranial neural crest during tooth and 
mandibular morphogenesis. Development 127, 1671-1679. 
 
Chai, Y., Jiang, X.B., Ito, Y., Bringas, P., Han, J., Rowitch, D.H., Soriano, P., McMahon, 
A.P., Sucov, H.M., 2000b. Fate of the mammalian cranial neural crest during tooth and 
mandibular morphogenesis. Development 127, 1671-1679. 
 
Chiang, C., Litingtung, Y., Lee, E., Young, K.E., Corden, J.L., Westphal, H., Beachy, P.A., 
1996. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene 
function. Nature 383, 407-413. 
 
Choi, M., Klingensmith, J., 2009. Chordin is a modifier of tbx1 for the craniofacial 
malformations of 22q11 deletion syndrome phenotypes in mouse. PLoS genetics 5, 
e1000395. 
 
Cohen, M.M., MacLean, R.E., 2000. Craniosynostosis : diagnosis, evaluation, and 
management, 2nd ed. Oxford University Press, New York. 
 
  165 
Cooper, A.F., Yu, K.P., Brueckner, M., Brailey, L.L., Johnson, L., McGrath, J.M., Bale, 
A.E., 2005. Cardiac and CNS defects in a mouse with targeted disruption of suppressor 
of fused. Development 132, 4407-4417. 
 
Copp, A.J., Greene, N.D., Murdoch, J.N., 2003. The genetic basis of mammalian 
neurulation. Nature reviews. Genetics 4, 784-793. 
 
Couly, G., Creuzet, S., Bennaceur, S., Vincent, C., Le Douarin, N.M., 2002. Interactions 
between Hox-negative cephalic neural crest cells and the foregut endoderm in 
patterning the facial skeleton in the vertebrate head. Development 129, 1061-1073. 
 
Couly, G.F., Coltey, P.M., Ledouarin, N.M., 1993. The Triple Origin of Skull in Higher 
Vertebrates - a Study in Quail-Chick Chimeras. Development 117, 409-429. 
 
d'Amaro, R., Scheidegger, R., Blumer, S., Pazera, P., Katsaros, C., Graf, D., Chiquet, M., 
2012. Putative functions of extracellular matrix glycoproteins in secondary palate 
morphogenesis. Frontiers in physiology 3, 377. 
 
Danielian, P.S., Muccino, D., Rowitch, D.H., Michael, S.K., McMahon, A.P., 1998. 
Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form 
of Cre recombinase. Current biology : CB 8, 1323-1326. 
 
Daskalogiannakis, J., Ross, R.B., Tompson, B.D., 2001. The mandibular catch-up growth 
controversy in Pierre Robin sequence. Am J Orthod Dentofacial Orthop 120, 280-285. 
 
De Coster, P.J., Mortier, G., Marks, L.A., Martens, L.C., 2007. Cranial suture biology and 
dental development: genetic and clinical perspectives. J Oral Pathol Med 36, 447-455. 
 
Dudas, M., Sridurongrit, S., Nagy, A., Okazaki, K., Kaartinen, V., 2004. Craniofacial 
defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech Dev 121, 
173-182. 
 
Eom, D.S., Amarnath, S., Agarwala, S., 2013. Apicobasal polarity and neural tube 
closure. Development, growth & differentiation 55, 164-172. 
 
Eom, D.S., Amarnath, S., Fogel, J.L., Agarwala, S., 2011. Bone morphogenetic proteins 
regulate neural tube closure by interacting with the apicobasal polarity pathway. 
Development 138, 3179-3188. 
  166 
Eom, D.S., Amarnath, S., Fogel, J.L., Agarwala, S., 2012. Bone morphogenetic proteins 
regulate hinge point formation during neural tube closure by dynamic modulation of 
apicobasal polarity. Birth defects research. Part A, Clinical and molecular teratology 94, 
804-816. 
 
Figueroa, A.A., 2002. Long-term outcome study of bilateral mandibular distraction: A 
comparison of Treacher Collins and Nager syndromes to other types of micrognathia - 
Discussion. Plast Reconstr Surg 109, 1826-1827. 
 
Fleming, A., Copp, A.J., 2000. A genetic risk factor for mouse neural tube defects: 
defining the embryonic basis. Human molecular genetics 9, 575-581. 
 
Frommer, J., Margolie.Mr, 1971. Contribution of Meckels Cartilage to Ossification of 
Mandible in Mice. Journal of Dental Research 50, 1260-&. 
 
Fuchs, A., Inthal, A., Herrmann, D., Cheng, S., Nakatomi, M., Peters, H., Neubuser, A., 
2010. Regulation of Tbx22 during facial and palatal development. Dev Dyn 239, 2860-
2874. 
 
Gato, A., Martinez, M.L., Tudela, C., Alonso, I., Moro, J.A., Formoso, M.A., Ferguson, 
M.W., Martinez-Alvarez, C., 2002. TGF-beta(3)-induced chondroitin sulphate 
proteoglycan mediates palatal shelf adhesion. Dev Biol 250, 393-405. 
 
Goldstein, A.M., Brewer, K.C., Doyle, A.M., Nagy, N., Roberts, D.J., 2005. BMP signaling 
is necessary for neural crest cell migration and ganglion formation in the enteric nervous 
system. Mech Dev 122, 821-833. 
 
Goodrich, J.T., 2005. Skull base growth in craniosynostosis. Childs Nerv Syst 21, 871-879. 
 
Goodrich, L.V., Jung, D., Higgins, K.M., Scott, M.P., 1999. Overexpression of ptc1 
inhibits induction of Shh target genes and prevents normal patterning in the neural tube. 
Developmental biology 211, 323-334. 
 
Goodrich, L.V., Milenkovic, L., Higgins, K.M., Scott, M.P., 1997. Altered neural cell fates 
and medulloblastoma in mouse patched mutants. Science 277, 1109-1113. 
 
  167 
Grewal, J., Carmichael, S.L., Ma, C., Lammer, E.J., Shaw, G.M., 2008. Maternal 
periconceptional smoking and alcohol consumption and risk for select congenital 
anomalies. Birth defects research. Part A, Clinical and molecular teratology 82, 519-526. 
 
Hall, R.J., Erickson, C.A., 2003. ADAM 10: an active metalloprotease expressed during 
avian epithelial morphogenesis. Dev Biol 256, 146-159. 
 
Harfe, B.D., Scherz, P.J., Nissim, S., Tian, H., McMahon, A.P., Tabin, C.J., 2004. Evidence 
for an expansion-based temporal Shh gradient in specifying vertebrate digit identities. 
Cell 118, 517-528. 
 
Harris, E.F., 1993. Size and form of the cranial base in isolated cleft lip and palate. Cleft 
Palate Craniofac J 30, 170-174. 
 
He, F., Xiong, W., Wang, Y., Li, L., Liu, C., Yamagami, T., Taketo, M.M., Zhou, C., Chen, 
Y., 2011. Epithelial Wnt/beta-catenin signaling regulates palatal shelf fusion through 
regulation of Tgfbeta3 expression. Dev Biol 350, 511-519. 
 
He, F., Xiong, W., Wang, Y., Matsui, M., Yu, X., Chai, Y., Klingensmith, J., Chen, Y., 2010. 
Modulation of BMP signaling by Noggin is required for the maintenance of palatal 
epithelial integrity during palatogenesis. Developmental biology 347, 109-121. 
 
Hennekam, R.C., Van den Boogaard, M.J., 1990. Autosomal dominant craniosynostosis 
of the sutura metopica. Clin Genet 38, 374-377. 
 
Higashihori, N., Buchtova, M., Richman, J.M., 2010. The function and regulation of 
TBX22 in avian frontonasal morphogenesis. Dev Dyn 239, 458-473. 
 
Hogan, B., 1994. Manipulating the mouse embryo : a laboratory manual, 2nd ed. Cold 
Spring Harbor Laboratory Press, Plainview, N.Y. 
 
Holder-Espinasse, M., Abadie, V., Cormier-Daire, V., Beyler, C., Manach, Y., Munnich, 
A., Lyonnet, S., Couly, G., Amiel, J., 2001. Pierre Robin sequence: a series of 117 
consecutive cases. The Journal of pediatrics 139, 588-590. 
 
Honein, M.A., Rasmussen, S.A., Reefhuis, J., Romitti, P.A., Lammer, E.J., Sun, L.X., 
Correa, A., 2007. Maternal smoking and environmental tobacco smoke exposure and the 
risk of orofacial clefts. Epidemiology 18, 226-233. 
  168 
Hsu, D.R., Economides, A.N., Wang, X., Eimon, P.M., Harland, R.M., 1998. The Xenopus 
dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize 
BMP activities. Molecular cell 1, 673-683. 
 
Hu, D., Colnot, C., Marcucio, R.S., 2008. Effect of bone morphogenetic protein signaling 
on development of the jaw skeleton. Developmental dynamics : an official publication of 
the American Association of Anatomists 237, 3727-3737. 
 
Huang, X., Yokota, T., Iwata, J., Chai, Y., 2011. Tgf-beta-mediated FasL-Fas-Caspase 
pathway is crucial during palatogenesis. J Dent Res 90, 981-987. 
 
Iida, A., Ohashi, Y., Ono, K., Imai, N., Kannari, Y., 1995. Craniosynostosis with joint 
contractures, ear deformity, cleft palate, scoliosis, and other features. The Cleft palate-
craniofacial journal : official publication of the American Cleft Palate-Craniofacial 
Association 32, 489-493. 
 
Ikeda, A., Ikeda, S., Gridley, T., Nishina, P.M., Naggert, J.K., 2001. Neural tube defects 
and neuroepithelial cell death in Tulp3 knockout mice. Human molecular genetics 10, 
1325-1334. 
 
Jeong, J., Mao, J., Tenzen, T., Kottmann, A.H., McMahon, A.P., 2004. Hedgehog signaling 
in the neural crest cells regulates the patterning and growth of facial primordia. Genes & 
development 18, 937-951. 
 
Jeong, J., Tenzen, T., McMahon, A.P., 2003. Direct hedgehog signaling in the neural crest 
cells is essential for the normal craniofacial development. Developmental Biology 259, 
551-551. 
 
Jiang, X., Rowitch, D.H., Soriano, P., McMahon, A.P., Sucov, H.M., 2000. Fate of the 
mammalian cardiac neural crest. Development 127, 1607-1616. 
 
Jin, J.Z., Ding, J., 2006. Analysis of cell migration, transdifferentiation and apoptosis 
during mouse secondary palate fusion. Development 133, 3341-3347. 
 
Johnson, C.P., Fujimoto, I., Rutishauser, U., Leckband, D.E., 2005. Direct evidence that 
neural cell adhesion molecule (NCAM) polysialylation increases intermembrane 
repulsion and abrogates adhesion. The Journal of biological chemistry 280, 137-145. 
  169 
Kaartinen, V., Voncken, J.W., Shuler, C., Warburton, D., Bu, D., Heisterkamp, N., 
Groffen, J., 1995. Abnormal Lung Development and Cleft-Palate in Mice Lacking Tgf-
Beta-3 Indicates Defects of Epithelial-Mesenchymal Interaction. Nature Genetics 11, 415-
421. 
 
Kanzler, B., Foreman, R.K., Labosky, P.A., Mallo, M., 2000. BMP signaling is essential for 
development of skeletogenic and neurogenic cranial neural crest. Development 127, 
1095-1104. 
 
Kawakami, T., Kawcak, T., Li, Y.J., Zhang, W., Hu, Y., Chuang, P.T., 2002. Mouse 
dispatched mutants fail to distribute hedgehog proteins and are defective in hedgehog 
signaling. Development 129, 5753-5765. 
 
Kimonis, V., Gold, J.A., Hoffman, T.L., Panchal, J., Boyadjiev, S.A., 2007. Genetics of 
craniosynostosis. Semin Pediatr Neurol 14, 150-161. 
 
Klingensmith, J., Matsui, M., Yang, Y.P., Anderson, R.M., 2010. Roles of bone 
morphogenetic protein signaling and its antagonism in holoprosencephaly. American 
journal of medical genetics. Part C, Seminars in medical genetics 154C, 43-51. 
 
Koressaar, T., Remm, M., 2007. Enhancements and modifications of primer design 
program Primer3. Bioinformatics 23, 1289-1291. 
 
Lammer, E.J., Shaw, G.M., Iovannisci, D.M., Van Waes, J., Finnell, R.H., 2004. Maternal 
smoking and the risk of orofacial clefts - Susceptibility with NAT1 and NAT2 
polymorphisms. Epidemiology 15, 150-156. 
 
Lana-Elola, E., Tylzanowski, P., Takatalo, M., Alakurtti, K., Veistinen, L., Mitsiadis, T.A., 
Graf, D., Rice, R., Luyten, F.P., Rice, D.P., 2011. Noggin null allele mice exhibit a 
microform of holoprosencephaly. Human molecular genetics 20, 4005-4015. 
 
Lewis, J.E., Wahl, J.K., 3rd, Sass, K.M., Jensen, P.J., Johnson, K.R., Wheelock, M.J., 1997. 
Cross-talk between adherens junctions and desmosomes depends on plakoglobin. The 
Journal of cell biology 136, 919-934. 
 
Li, L., Lin, M.K., Wang, Y., Cserjesi, P., Chen, Z., Chen, Y.P., 2011. BmprIa is required in 
mesenchymal tissue and has limited redundant function with BmprIb in tooth and 
palate development. Developmental Biology 349, 451-461. 
  170 
Li, L., Wang, Y., Lin, M., Yuan, G., Yang, G., Zheng, Y., Chen, Y., 2013. Augmented 
BMPRIA-mediated BMP signaling in cranial neural crest lineage leads to cleft palate 
formation and delayed tooth differentiation. PloS one 8, e66107. 
 
Lieberman, D.E., Pearson, O.M., Mowbray, K.M., 2000. Basicranial influence on overall 
cranial shape. Journal of Human Evolution 38, 291-315. 
 
Lotz, M.M., Burdsal, C.A., Erickson, H.P., McClay, D.R., 1989. Cell adhesion to 
fibronectin and tenascin: quantitative measurements of initial binding and subsequent 
strengthening response. The Journal of cell biology 109, 1795-1805. 
 
Lozanoff, S., Jureczek, S., Feng, T., Padwal, R., 1994. Anterior cranial base morphology in 
mice with midfacial retrusion. Cleft Palate Craniofac J 31, 417-428. 
 
Luo, Y., High, F.A., Epstein, J.A., Radice, G.L., 2006. N-cadherin is required for neural 
crest remodeling of the cardiac outflow tract. Developmental biology 299, 517-528. 
 
Matsui, M., Klingensmith, J., 2013. Development of the Craniofacial Skeleton, Primer on 
the Metabolic Bone Diseases and Disorders of Mineral Metabolism. John Wiley & Sons, 
Inc., pp. 893-903. 
 
McBratney-Owen, B., Iseki, S., Bamforth, S.D., Olsen, B.R., Morriss-Kay, G.M., 2008. 
Development and tissue origins of the mammalian cranial base. Developmental biology 
322, 121-132. 
 
McMahon, J.A., Takada, S., Zimmerman, L.B., Fan, C.M., Harland, R.M., McMahon, 
A.P., 1998. Noggin-mediated antagonism of BMP signaling is required for growth and 
patterning of the neural tube and somite. Genes & development 12, 1438-1452. 
 
Meigs, T.E., Fedor-Chaiken, M., Kaplan, D.D., Brackenbury, R., Casey, P.J., 2002. 
Galpha12 and Galpha13 negatively regulate the adhesive functions of cadherin. The 
Journal of biological chemistry 277, 24594-24600. 
 
Melnick, M., Witcher, D., Bringas, P., Jr., Carlsson, P., Jaskoll, T., 2005. Meckel's cartilage 
differentiation is dependent on hedgehog signaling. Cells Tissues Organs 179, 146-157. 
 
  171 
Menegaz, R.A., Sublett, S.V., Figueroa, S.D., Hoffman, T.J., Ravosa, M.J., 2009. 
Phenotypic plasticity and function of the hard palate in growing rabbits. Anatomical 
record 292, 277-284. 
 
Mina, M., Havens, B., Velonis, D.A., 2007. FGF signaling in mandibular skeletogenesis. 
Orthod Craniofac Res 10, 59-66. 
 
Mina, M., Wang, Y.H., Ivanisevic, A.M., Upholt, W.B., Rodgers, B., 2002. Region- and 
stage-specific effects of FGFs and BMPs in chick mandibular morphogenesis. Dev 
Dynam 223, 333-352. 
 
Minina, E., Kreschel, C., Naski, M.C., Ornitz, D.M., Vortkamp, A., 2002. Interaction of 
FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and 
hypertrophic differentiation. Developmental cell 3, 439-449. 
 
Minina, E., Wenzel, H.M., Kreschel, C., Karp, S., Gaffield, W., McMahon, A.P., 
Vortkamp, A., 2001. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte 
proliferation and differentiation. Development 128, 4523-4534. 
 
Molsted, K., Dahl, E., Skovgaard, L.T., Asher-McDade, C., Brattstrom, V., McCance, A., 
Prahl-Andersen, B., Semb, G., Shaw, B., The, R., 1993. A multicentre comparison of 
treatment regimens for unilateral cleft lip and palate using a multiple regression model. 
Scandinavian journal of plastic and reconstructive surgery and hand surgery / Nordisk 
plastikkirurgisk forening [and] Nordisk klubb for handkirurgi 27, 277-284. 
 
Molsted, K., Kjaer, I., Dahl, E., 1995. Cranial base in newborns with complete cleft lip 
and palate: radiographic study. Cleft Palate Craniofac J 32, 199-205. 
 
Mori-Akiyama, Y., Akiyama, H., Rowitch, D.H., de Crombrugghe, B., 2003. Sox9 is 
required for determination of the chondrogenic cell lineage in the cranial neural crest. 
Proc Natl Acad Sci U S A 100, 9360-9365. 
 
Morris-Wiman, J., Brinkley, L., 1992. An extracellular matrix infrastructure provides 
support for murine secondary palatal shelf remodelling. The Anatomical record 234, 
575-586. 
 
Mossey PA, L.J., 2002. Epidemiology of oral cleft: an internationa perspective. Oxford 
University Press, New York, NY. 
  172 
Moury, J.D., Schoenwolf, G.C., 1995. Cooperative model of epithelial shaping and 
bending during avian neurulation: autonomous movements of the neural plate, 
autonomous movements of the epidermis, and interactions in the neural plate/epidermis 
transition zone. Developmental dynamics : an official publication of the American 
Association of Anatomists 204, 323-337. 
 
Murdoch, J.N., Copp, A.J., 2010. The relationship between sonic Hedgehog signaling, 
cilia, and neural tube defects. Birth defects research. Part A, Clinical and molecular 
teratology 88, 633-652. 
 
Nawshad, A., Medici, D., Liu, C.C., Hay, E.D., 2007. TGFbeta3 inhibits E-cadherin gene 
expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 
transcription complex. J Cell Sci 120, 1646-1653. 
 
Nie, X.G., 2005. Cranial base in craniofacial development: Developmental features, 
influence on facial growth, anomaly, and molecular basis. Acta Odontol Scand 63, 127-
135. 
 
Nifuji, A., Noda, M., 1999. Coordinated expression of noggin and bone morphogenetic 
proteins (BMPs) during early skeletogenesis and induction of noggin expression by 
BMP-7. Journal of bone and mineral research : the official journal of the American 
Society for Bone and Mineral Research 14, 2057-2066. 
 
Norman, R.X., Ko, H.W., Huang, V., Eun, C.M., Abler, L.L., Zhang, Z., Sun, X., 
Eggenschwiler, J.T., 2009. Tubby-like protein 3 (TULP3) regulates patterning in the 
mouse embryo through inhibition of Hedgehog signaling. Human molecular genetics 
18, 1740-1754. 
 
Ogle, R.C., Tholpady, S.S., McGlynn, K.A., Ogle, R.A., 2004. Regulation of cranial suture 
morphogenesis. Cells Tissues Organs 176, 54-66. 
 
Patterson, V.L., Damrau, C., Paudyal, A., Reeve, B., Grimes, D.T., Stewart, M.E., 
Williams, D.J., Siggers, P., Greenfield, A., Murdoch, J.N., 2009. Mouse hitchhiker 
mutants have spina bifida, dorso-ventral patterning defects and polydactyly: 
identification of Tulp3 as a novel negative regulator of the Sonic hedgehog pathway. 
Human molecular genetics 18, 1719-1739. 
  173 
Pauws, E., Moore, G.E., Stanier, P., 2009. A functional haplotype variant in the TBX22 
promoter is associated with cleft palate and ankyloglossia. Journal of medical genetics 
46, 555-561. 
 
Potti, T.A., Petty, E.M., Lesperance, M.M., 2011. A comprehensive review of reported 
heritable noggin-associated syndromes and proposed clinical utility of one broadly 
inclusive diagnostic term: NOG-related-symphalangism spectrum disorder (NOG-SSD). 
Human mutation 32, 877-886. 
 
Proetzel, G., Pawlowski, S.A., Wiles, M.V., Yin, M.Y., Boivin, G.P., Howles, P.N., Ding, 
J.X., Ferguson, M.W.J., Doetschman, T., 1995. Transforming Growth Factor-Beta-3 Is 
Required for Secondary Palate Fusion. Nature Genetics 11, 409-414. 
 
Pruzinsky, T., 1992. Social and psychological effects of major craniofacial deformity. 
Cleft Palate Craniofac J 29, 578-584; discussion 570. 
 
Pyrgaki, C., Liu, A., Niswander, L., 2011. Grainyhead-like 2 regulates neural tube closure 
and adhesion molecule expression during neural fold fusion. Developmental biology 
353, 38-49. 
 
Ramaesh, T., Bard, J.B., 2003. The growth and morphogenesis of the early mouse 
mandible: a quantitative analysis. Journal of anatomy 203, 213-222. 
 
Reshef, R., Maroto, M., Lassar, A.B., 1998. Regulation of dorsal somitic cell fates: BMPs 
and Noggin control the timing and pattern of myogenic regulator expression. Genes & 
development 12, 290-303. 
 
Rice, R., Spencer-Dene, B., Connor, E.C., Gritli-Linde, A., McMahon, A.P., Dickson, C., 
Thesleff, I., Rice, D.P., 2004. Disruption of Fgf10/Fgfr2b-coordinated epithelial-
mesenchymal interactions causes cleft palate. The Journal of clinical investigation 113, 
1692-1700. 
 
Richtsmeier, J.T., Aldridge, K., DeLeon, V.B., Panchal, J., Kane, A.A., Marsh, J.L., Yan, P., 
Cole, T.M., 3rd, 2006. Phenotypic integration of neurocranium and brain. J Exp Zool B 
Mol Dev Evol 306, 360-378. 
 
  174 
Rifat, Y., Parekh, V., Wilanowski, T., Hislop, N.R., Auden, A., Ting, S.B., Cunningham, 
J.M., Jane, S.M., 2010. Regional neural tube closure defined by the Grainy head-like 
transcription factors. Developmental biology 345, 237-245. 
 
Rodriguez, P., Da Silva, S., Oxburgh, L., Wang, F., Hogan, B.L., Que, J., 2010. BMP 
signaling in the development of the mouse esophagus and forestomach. Development 
137, 4171-4176. 
 
Sahar, D.E., Longaker, M.T., Quarto, N., 2005. Sox9 neural crest determinant gene 
controls patterning and closure of the posterior frontal cranial suture. Developmental 
biology 280, 344-361. 
 
Satokata, I., Maas, R., 1994. Msx1 Deficient Mice Exhibit Cleft-Palate and Abnormalities 
of Craniofacial and Tooth Development. Nature Genetics 6, 348-356. 
 
Scott, I.C., Blitz, I.L., Pappano, W.N., Maas, S.A., Cho, K.W., Greenspan, D.S., 2001. 
Homologues of Twisted gastrulation are extracellular cofactors in antagonism of BMP 
signalling. Nature 410, 475-478. 
 
Shoval, I., Ludwig, A., Kalcheim, C., 2007. Antagonistic roles of full-length N-cadherin 
and its soluble BMP cleavage product in neural crest delamination. Development 134, 
491-501. 
 
St-Jacques, B., Hammerschmidt, M., McMahon, A.P., 1999. Indian hedgehog signaling 
regulates proliferation and differentiation of chondrocytes and is essential for bone 
formation. Genes Dev 13, 2072-2086. 
 
Stafford, D.A., Brunet, L.J., Khokha, M.K., Economides, A.N., Harland, R.M., 2011. 
Cooperative activity of noggin and gremlin 1 in axial skeleton development. 
Development 138, 1005-1014. 
 
Stanier, P., Moore, G.E., 2004. Genetics of cleft lip and palate: syndromic genes 
contribute to the incidence of non-syndromic clefts. Hum Mol Genet 13, R73-R81. 
 
Stottmann, R.W., Anderson, R.M., Klingensmith, J., 2001. The BMP antagonists Chordin 
and Noggin have essential but redundant roles in mouse mandibular outgrowth. 
Developmental biology 240, 457-473. 
  175 
Stottmann, R.W., Berrong, M., Matta, K., Choi, M., Klingensmith, J., 2006. The BMP 
antagonist Noggin promotes cranial and spinal neurulation by distinct mechanisms. 
Developmental biology 295, 647-663. 
 
Stottmann, R.W., Klingensmith, J., 2011. Bone morphogenetic protein signaling is 
required in the dorsal neural folds before neurulation for the induction of spinal neural 
crest cells and dorsal neurons. Dev Dyn 240, 755-765. 
 
Suri, S., Ross, R.B., Tompson, B.D., 2010. Craniofacial morphology and adolescent facial 
growth in Pierre Robin sequence. Am J Orthod Dentofac 137, 763-774. 
 
Tao, J., Kuliyev, E., Wang, X., Li, X., Wilanowski, T., Jane, S.M., Mead, P.E., 
Cunningham, J.M., 2005. BMP4-dependent expression of Xenopus Grainyhead-like 1 is 
essential for epidermal differentiation. Development 132, 1021-1034. 
 
Taya, Y., O'Kane, S., Ferguson, M.W., 1999a. Pathogenesis of cleft palate in TGF-beta3 
knockout mice. Development 126, 3869-3879. 
 
Taya, Y., O'Kane, S., Ferguson, M.W.J., 1999b. Pathogenesis of cleft palate in TGF-beta 3 
knockout mice. Development 126, 3869-3879. 
 
Trumpp, A., Depew, M.J., Rubenstein, J.L., Bishop, J.M., Martin, G.R., 1999. Cre-
mediated gene inactivation demonstrates that FGF8 is required for cell survival and 
patterning of the first branchial arch. Genes & development 13, 3136-3148. 
 
Tsuzurahara, F., Soeta, S., Kawawa, T., Baba, K., Nakamura, M., 2011. The role of 
macrophages in the disappearance of Meckel's cartilage during mandibular 
development in mice. Acta Histochem 113, 194-200. 
 
Tucker, A.S., Yamada, G., Grigoriou, M., Pachnis, V., Sharpe, P.T., 1999. Fgf-8 
determines rostral-caudal polarity in the first branchial arch. Development 126, 51-61. 
 
Wallingford, J.B., Niswander, L.A., Shaw, G.M., Finnell, R.H., 2013. The continuing 
challenge of understanding, preventing, and treating neural tube defects. Science 339, 
1222002. 
 
  176 
Wang, Y., Zheng, Y., Chen, D., Chen, Y., 2013. Enhanced BMP signaling prevents 
degeneration and leads to endochondral ossification of Meckel's cartilage in mice. 
Developmental biology 381, 301-311. 
 
Warren, S.M., Brunet, L.J., Harland, R.M., Economides, A.N., Longaker, M.T., 2003. The 
BMP antagonist noggin regulates cranial suture fusion. Nature 422, 625-629. 
 
Werth, M., Walentin, K., Aue, A., Schonheit, J., Wuebken, A., Pode-Shakked, N., 
Vilianovitch, L., Erdmann, B., Dekel, B., Bader, M., Barasch, J., Rosenbauer, F., Luft, F.C., 
Schmidt-Ott, K.M., 2010. The transcription factor grainyhead-like 2 regulates the 
molecular composition of the epithelial apical junctional complex. Development 137, 
3835-3845. 
 
Weseman, C.M., 1959. Congenital Micrognathia. Archiv Otolaryngol 69, 31-44. 
Wijgerde, M., Karp, S., McMahon, J., McMahon, A.P., 2005. Noggin antagonism of BMP4 
signaling controls development of the axial skeleton in the mouse. Developmental 
biology 286, 149-157. 
 
Wilke, T.A., Gubbels, S., Schwartz, J., Richman, J.M., 1997. Expression of fibroblast 
growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face. Dev 
Dynam 210, 41-52. 
 
Xu, X., Han, J., Ito, Y., Bringas, P., Jr., Urata, M.M., Chai, Y., 2006. Cell autonomous 
requirement for Tgfbr2 in the disappearance of medial edge epithelium during palatal 
fusion. Dev Biol 297, 238-248. 
 
Ybot-Gonzalez, P., Cogram, P., Gerrelli, D., Copp, A.J., 2002. Sonic hedgehog and the 
molecular regulation of mouse neural tube closure. Development 129, 2507-2517. 
 
Ybot-Gonzalez, P., Gaston-Massuet, C., Girdler, G., Klingensmith, J., Arkell, R., Greene, 
N.D., Copp, A.J., 2007. Neural plate morphogenesis during mouse neurulation is 
regulated by antagonism of Bmp signalling. Development 134, 3203-3211. 
 
Yu, L., Gu, S., Alappat, S., Song, Y., Yan, M., Zhang, X., Zhang, G., Jiang, Y., Zhang, Z., 
Zhang, Y., Chen, Y., 2005. Shox2-deficient mice exhibit a rare type of incomplete clefting 
of the secondary palate. Development 132, 4397-4406. 
  177 
Zhang, X.M., Ramalho-Santos, M., McMahon, A.P., 2001. Smoothened mutants reveal 
redundant roles for Shh and Ihh signaling including regulation of L/R symmetry by the 
mouse node. Cell 106, 781-792. 
 
Zhang, Z., Song, Y., Zhao, X., Zhang, X., Fermin, C., Chen, Y., 2002. Rescue of cleft palate 
in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling 
in the regulation of mammalian palatogenesis. Development 129, 4135-4146. 
 
Zucchero, T.M., Cooper, M.E., Maher, B.S., Daack-Hirsch, S., Nepomuceno, B., Ribeiro, 
L., Caprau, D., Christensen, K., Suzuki, Y., Machida, J., Natsume, N., Yoshiura, K.I., 
Vieira, A.R., Orioli, I.M., Castilla, E.E., Moreno, L., Arcos-Burgos, M., Lidral, A.C., Field, 
L.L., Liu, Y.E., Ray, A., Goldstein, T.H., Schultz, R.E., Shi, M., Johnson, M.K., Kondo, S., 
Schutte, B.C., Marazita, M.L., Murray, J.C., 2004. Interferon regulatory factor 6 (IRF6) 
gene variants and the risk of isolated cleft lip or palate. New Engl J Med 351, 769-780. 
 
  178 
Biography 
Maiko Matsui studies developmental biology and is interested in craniofacial 
development in mammals. In her current research, she tries to identify the mechanisms 
that lead to abnormal and normal development of craniofacial skeletal structures.  
At Duke University, she holds a Graduate School fellowship. Prior to joining 
Duke, she attended University of North Carolina-Greensboro, where she earned a B.S. in 
Biology with honors in 2006. Maiko was born in Kyoto, Japan.  
Her list of publications includes: 
Matsui M, and Klingensmith J. (2013) Development of the Craniofacial Skeleton. in CJ 
Rosen, R Bouillon, JE Compston, and V Rosen (eds.) Primer on the Metabolic Bone Diseases 
and Disorders of Mineral Metabolism 893-903. 
 
Matsui M, Sharma KC, Cooke C, Wakimoto BT, Rasool M, Hayworth M, Hylton CA, 
and Tomkiel JE. (2011) Nuclear structure and chromosome segregation in Drosophila 
male meiosis depend on the ubiquitin ligase dTopors. Genetics. 189(3): 779-93. 
 
He F, Xiong W, Wang Y, Matsui M, Yu X, Chai Y, Klingensmith J, and Chen Y. (2010) 
Modulation of BMP signaling by Noggin is required for the maintenace of palatal 
epithelial integrity during palatogenesis. Dev Biol. 374(1): 109-21. 
 
Klingensmith J, Matsui M, Yang YP, and Anderson RM. (2010) Roles of bone 
morphogenetic protein signaling and its antagonism in holoprosencephaly. Am J Med 
Genet C Semin Med Genet. 154C(1): 43-51 
 
 
 
 
